<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="pmc-domain-id">808</journal-id><journal-id journal-id-type="pmc-domain">ijms</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6387265</article-id><article-id pub-id-type="pmcid-ver">PMC6387265.1</article-id><article-id pub-id-type="pmcaid">6387265</article-id><article-id pub-id-type="pmcaiid">6387265</article-id><article-id pub-id-type="pmid">30700023</article-id><article-id pub-id-type="doi">10.3390/ijms20030584</article-id><article-id pub-id-type="publisher-id">ijms-20-00584</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Acute and Chronic Effects of Cocaine on Cardiovascular Health</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8852-0198</contrib-id><name name-style="western"><surname>Kim</surname><given-names initials="ST">Sung Tae</given-names></name><xref ref-type="aff" rid="af1-ijms-20-00584">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0327-1311</contrib-id><name name-style="western"><surname>Park</surname><given-names initials="T">Taehwan</given-names></name><xref ref-type="aff" rid="af2-ijms-20-00584">2</xref><xref ref-type="aff" rid="af3-ijms-20-00584">3</xref><xref rid="c1-ijms-20-00584" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-20-00584"><label>1</label>Department of Pharmaceutical Engineering, Inje University, Gimhae 50834, Korea; <email>stkim@inje.ac.kr</email></aff><aff id="af2-ijms-20-00584"><label>2</label>Pharmacy Administration, St. Louis College of Pharmacy, St. Louis, MO 63110, USA</aff><aff id="af3-ijms-20-00584"><label>3</label>Center for Health Outcomes Research and Education, St. Louis College of Pharmacy, St. Louis, MO 63110, USA</aff><author-notes><corresp id="c1-ijms-20-00584"><label>*</label>Correspondence: <email>Taehwan.Park@stlcop.edu</email>; Tel.: +1-314-446-8193</corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2019</year></pub-date><volume>20</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">330004</issue-id><elocation-id>584</elocation-id><history><date date-type="received"><day>08</day><month>1</month><year>2019</year></date><date date-type="accepted"><day>27</day><month>1</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>02</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>27</day><month>02</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-04-13 03:10:12.197"><day>13</day><month>04</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ijms-20-00584.pdf"/><abstract><p>Cardiac complications resulting from cocaine use have been extensively studied because of the complicated pathophysiological mechanisms. This study aims to review the underlying cellular and molecular mechanisms of acute and chronic effects of cocaine on the cardiovascular system with a specific focus on human studies. Studies have consistently reported the acute effects of cocaine on the heart (e.g., electrocardiographic abnormalities, acute hypertension, arrhythmia, and acute myocardial infarction) through multifactorial mechanisms. However, variable results have been reported for the chronic effects of cocaine. Some studies found no association of cocaine use with coronary artery disease (CAD), while others reported its association with subclinical coronary atherosclerosis. These inconsistent findings might be due to the heterogeneity of study subjects with regard to cardiac risk. After cocaine use, populations at high risk for CAD experienced coronary atherosclerosis whereas those at low risk did not experience CAD, suggesting that the chronic effects of cocaine were more likely to be prominent among individuals with higher CAD risk. Studies also suggested that risky behaviors and cardiovascular risks may affect the association between cocaine use and mortality. Our study findings highlight the need for education regarding the deleterious effects of cocaine, and access to interventions for cocaine abusers.</p></abstract><kwd-group><kwd>cocaine</kwd><kwd>cardiovascular health</kwd><kwd>heart disease</kwd><kwd>acute effects</kwd><kwd>chronic effects</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-20-00584"><title>1. Introduction</title><p>Cocaine is a tropane alkaloid compound that can be extracted from the leaves of an Andean shrub, <italic toggle="yes">Erythroxylon coca</italic>, in South America. Cocaine was originally used for local surgeries as an anesthetic agent in the 1880s, but it became a recreational drug in the 1970s. In the 1980s, there was an epidemic of cocaine use, with the number of cocaine users in the US estimated at 5.8 million in 1985 [<xref rid="B1-ijms-20-00584" ref-type="bibr">1</xref>]. In 2016, the total number of cocaine users was estimated to be 18.2 million worldwide [<xref rid="B2-ijms-20-00584" ref-type="bibr">2</xref>]. Approximately 34% of these cocaine users resided in North America, and 20% resided in Western and Central Europe. In the US, there were 1.5 million cocaine users aged 12 or older, representing 0.6% of the population [<xref rid="B3-ijms-20-00584" ref-type="bibr">3</xref>]. Young adults aged 18 to 25 were the most common cocaine users (1.4%).</p><p>Cocaine may be administered by smoking, intravenous injection, nasal inhalation, or oral application. Pharmacokinetics vary by route of administration, with time to peak blood concentration ranging from 1&#8211;5 min (smoking or intravenous injection) to 60&#8211;90 min (oral administration) [<xref rid="B4-ijms-20-00584" ref-type="bibr">4</xref>,<xref rid="B5-ijms-20-00584" ref-type="bibr">5</xref>]. The duration of pharmacological action ranges between 5&#8211;60 min following smoking or intravenous administration, and up to 180 min following oral administration. In addition to nasal mucous membranes, cocaine absorption through other mucous membranes such as intravaginal or intrarectal mucus membranes is also possible [<xref rid="B6-ijms-20-00584" ref-type="bibr">6</xref>]. Cocaine administration through mucous membranes results in slower onset of action, later peak concentration, and longer duration of action compared with that of smoking or intravenous administration, but faster onset of action, earlier peak concentration, and shorter duration of action than that of oral administration. Cocaine is converted into two major metabolites by plasma and liver cholinesterases: benzoylecgonine and ecgonine methyl ester. These water-soluble metabolites are excreted in the urine and are detectable in the urine for 24 to 36 h after intake.</p><p>Cocaine is categorized as a Schedule II substance under the Controlled Substances Act. Drugs or substances in this schedule have a high potential for abuse, which may lead to severe psychological or physical dependence. Cocaine abuse can result in a range of adverse health outcomes. About 0.9 million U.S. adults had a cocaine use disorder in 2014 [<xref rid="B7-ijms-20-00584" ref-type="bibr">7</xref>]. Approximately 40% of all emergency department visits related to drug misuse and abuse were attributed to cocaine [<xref rid="B8-ijms-20-00584" ref-type="bibr">8</xref>].</p><p>Prior studies have consistently reported the deleterious effects of cocaine use/abuse on the cardiovascular system. Cocaine-related cardiac complications include acute conditions such as arrhythmia and acute myocardial infarction (MI), as well as chronic conditions such as cardiomyopathy and coronary artery disease (CAD). Cocaine-induced cardiotoxicity can result in sudden death. In addition, previous studies have explored the complicated pathophysiological mechanisms of cocaine cardiotoxicity. Herein, we first review the cellular and molecular mechanisms of cocaine in the cardiovascular system to obtain a better understanding of its acute and chronic effects on the heart and blood vessels. Furthermore, we discuss recent evidence from human studies that examined cocaine-associated changes in the cardiovascular system. As such, our review includes recent clinical studies that have been published in the past 10 years (from September 2008 through September 2018) retrieved from the Medline database, and several other important clinical studies published before September 2008.</p></sec><sec id="sec2-ijms-20-00584"><title>2. Pathophysiological Mechanisms of Cocaine on Cardiovascular Health</title><p>Cocaine stimulates the sympathetic nervous system by inhibiting reuptake of norepinephrine, dopamine, and serotonin by interacting with each transporter, leading to exaggerated, prolonged sympathetic nervous system activity [<xref rid="B9-ijms-20-00584" ref-type="bibr">9</xref>,<xref rid="B10-ijms-20-00584" ref-type="bibr">10</xref>]. Cocaine also blocks sodium/potassium channels, which induces abnormal, depressed cardiovascular profiles [<xref rid="B11-ijms-20-00584" ref-type="bibr">11</xref>]. In particular, concurrent cocaine and alcohol abuse significantly increases cocaine levels in the blood, leading to increased, prolonged cardiovascular risks [<xref rid="B12-ijms-20-00584" ref-type="bibr">12</xref>]. Previous studies have reported that use/abuse of cocaine is associated with increased risk of subsequent cardiovascular complications such as hypertension, coronary spasm, arrhythmias, MI, cardiomyopathy, atherosclerosis, and CAD [<xref rid="B13-ijms-20-00584" ref-type="bibr">13</xref>], as summarized in <xref ref-type="fig" rid="ijms-20-00584-f001">Figure 1</xref>. In this section, we summarize the acute and chronic pathophysiological mechanisms of cocaine on cardiovascular health.</p><sec id="sec2dot1-ijms-20-00584"><title>2.1. Mechanisms of Acute Toxicity</title><sec id="sec2dot1dot1-ijms-20-00584"><title>2.1.1. Acute Hypertension and Coronary Spasm</title><p>Acute coronary events usually occur within minutes to hours after cocaine administration. Cocaine stimulates the adrenergic system by binding to norepinephrine transporters, resulting in increased norepinephrine effects at postsynaptic receptor sites. Blocking norepinephrine reuptake induces tachycardia and hypertension, which increases myocardial oxygen demand and reduces myocardial oxygen supply by vasoconstriction [<xref rid="B11-ijms-20-00584" ref-type="bibr">11</xref>,<xref rid="B14-ijms-20-00584" ref-type="bibr">14</xref>,<xref rid="B15-ijms-20-00584" ref-type="bibr">15</xref>]. As such, cocaine induces sympathetic effects on the cardiovascular system by enhanced inotropic and chronotropic effects through increased vasoconstriction. In particular, cocaine induces acute hypertension due to increased vasoconstriction induced by increased endothelin-1 [<xref rid="B16-ijms-20-00584" ref-type="bibr">16</xref>], impaired acetylcholine-induced vasorelaxation [<xref rid="B17-ijms-20-00584" ref-type="bibr">17</xref>], inhibition of nitric oxide synthase [<xref rid="B18-ijms-20-00584" ref-type="bibr">18</xref>], impaired intracellular calcium handling [<xref rid="B19-ijms-20-00584" ref-type="bibr">19</xref>], and inhibition of sodium/potassium channels [<xref rid="B20-ijms-20-00584" ref-type="bibr">20</xref>] as determined by cellular and molecular analytical approaches [<xref rid="B11-ijms-20-00584" ref-type="bibr">11</xref>]. In addition, acute vessel damage induces platelet aggregation/blood clots through increased fibrinogen and von Willebrand factor, leading to acute heart damage due to reduced blood flow [<xref rid="B21-ijms-20-00584" ref-type="bibr">21</xref>]. Taken together, cocaine induces acute hypertension, coronary spasm, which may lead to subsequent myocardial infarction.</p></sec><sec id="sec2dot1dot2-ijms-20-00584"><title>2.1.2. Arrhythmias</title><p>Previous studies have shown that cocaine inhibits cardiac ion channels such as sodium channels and potassium channels [<xref rid="B22-ijms-20-00584" ref-type="bibr">22</xref>]. The upstroke of action potential was shown to be delayed in response to sodium channel blockade, which is modulated by heart rate and acidity. Increased heart rate and acidity boost the effect of cocaine on sodium channels [<xref rid="B23-ijms-20-00584" ref-type="bibr">23</xref>,<xref rid="B24-ijms-20-00584" ref-type="bibr">24</xref>]. Inhibition of sodium channels is intensified when cocaine is abused or when cocaethylene is formed after administration of cocaine with alcohol [<xref rid="B25-ijms-20-00584" ref-type="bibr">25</xref>,<xref rid="B26-ijms-20-00584" ref-type="bibr">26</xref>]. Cocaine effects on potassium channel blockade result in prolonged QT interval, early afterdepolarization, and ventricular tachyarrhythmia [<xref rid="B27-ijms-20-00584" ref-type="bibr">27</xref>,<xref rid="B28-ijms-20-00584" ref-type="bibr">28</xref>]. Similar to effects on sodium channels, cocaine abuse or cocaine use with alcohol exacerbates inhibition of potassium channels and QT prolongation [<xref rid="B29-ijms-20-00584" ref-type="bibr">29</xref>]. In addition, cocaine administration increases body temperature, resulting in hyperthermia. Cocaine overdose can induce cardiac arrhythmias and result in an impaired electrocardiographic profile, which may be related to the increased prevalence of cocaine-associated mortality in hot weather and in crowded circumstances [<xref rid="B30-ijms-20-00584" ref-type="bibr">30</xref>,<xref rid="B31-ijms-20-00584" ref-type="bibr">31</xref>]. In addition to these factors, cardiac arrhythmias may be affected by other factors such as catecholamine excess and calcium channel blockade. Acidosis and electrolyte abnormalities can also modulate cardiac arrhythmias. [<xref rid="B23-ijms-20-00584" ref-type="bibr">23</xref>]. As such, cocaine-induced cardiac arrhythmias can be generated via many mechanisms in cocaine users.</p></sec><sec id="sec2dot1dot3-ijms-20-00584"><title>2.1.3. Acute Myocardial Infarction</title><p>Mechanisms of acute MI resulting from cocaine use are multifactorial. Cocaine and its metabolites are sympathomimetic agents [<xref rid="B32-ijms-20-00584" ref-type="bibr">32</xref>] and induce local anesthetic effects [<xref rid="B11-ijms-20-00584" ref-type="bibr">11</xref>]. At low doses, cocaine-induced sympathetic effects increase heart rate, blood pressure, and myocardial contractibility, leading to increased myocardial oxygen demand [<xref rid="B33-ijms-20-00584" ref-type="bibr">33</xref>]. Cocaine also enhances coronary spasm/vasoconstriction and platelet adherence/thrombosis, leading to reduced myocardial oxygen supply [<xref rid="B34-ijms-20-00584" ref-type="bibr">34</xref>]. Thus, an imbalance between oxygen supply and demand results in MI [<xref rid="B35-ijms-20-00584" ref-type="bibr">35</xref>]. At high doses, cocaine-induced local anesthesia results in decreased left ventricular (LV) contractibility and prolongation of QRS and QT intervals in electrocardiograms by blocking sodium transport and norepinephrine uptake in the myocardium [<xref rid="B4-ijms-20-00584" ref-type="bibr">4</xref>]. In vessels, cocaine contributes to MI by increasing endothelin-1 [<xref rid="B36-ijms-20-00584" ref-type="bibr">36</xref>] and reducing nitric oxide production in endothelial cells [<xref rid="B37-ijms-20-00584" ref-type="bibr">37</xref>]. When vessels are stressed, acute damages/ruptures can occur, which promotes thrombosis by increasing platelet activity/aggregation [<xref rid="B38-ijms-20-00584" ref-type="bibr">38</xref>,<xref rid="B39-ijms-20-00584" ref-type="bibr">39</xref>] and elevating fibrinogen levels [<xref rid="B40-ijms-20-00584" ref-type="bibr">40</xref>] and plasminogen activator inhibitor activity [<xref rid="B41-ijms-20-00584" ref-type="bibr">41</xref>,<xref rid="B42-ijms-20-00584" ref-type="bibr">42</xref>]. These cellular and molecular cascades result in reduced cardiac blood flow, leading to acute MI and possibly atherosclerosis and coronary thrombosis in the long term [<xref rid="B43-ijms-20-00584" ref-type="bibr">43</xref>,<xref rid="B44-ijms-20-00584" ref-type="bibr">44</xref>]. As such, cocaine induces acute MI by directly affecting myocardial tissues in the heart and indirectly enhancing thrombosis in vessels.</p></sec></sec><sec id="sec2dot2-ijms-20-00584"><title>2.2. Mechanisms of Chronic Toxicity</title><sec id="sec2dot2dot1-ijms-20-00584"><title>2.2.1. Cardiomyopathy</title><p>Cocaine causes systolic dysfunction or LV failure, which results from reduced ejection fraction and an enlarged left ventricular chamber [<xref rid="B45-ijms-20-00584" ref-type="bibr">45</xref>]. Cocaine administration reduces myocardial contractility and ejection fraction [<xref rid="B46-ijms-20-00584" ref-type="bibr">46</xref>] and enhances left ventricular end-diastolic pressure and end-systolic volume [<xref rid="B47-ijms-20-00584" ref-type="bibr">47</xref>,<xref rid="B48-ijms-20-00584" ref-type="bibr">48</xref>,<xref rid="B49-ijms-20-00584" ref-type="bibr">49</xref>]. It may cause non-ischemic myocardial depression, leading to dilated cardiomyopathies such as Takotsubo cardiomyopathy, a type of non-ischemic cardiomyopathy [<xref rid="B50-ijms-20-00584" ref-type="bibr">50</xref>]. Previous studies reported that cocaine-induced cardiomyopathy, especially dilated cardiomyopathy [<xref rid="B51-ijms-20-00584" ref-type="bibr">51</xref>,<xref rid="B52-ijms-20-00584" ref-type="bibr">52</xref>], resulting from deprivation of myocardial oxygen supply despite increased demand for oxygen, leads to reduced coronary blood flow. Dilated cardiomyopathy is the most common consequence of long-term cocaine use and can lead to several complications including heart failure and heart-valve defects [<xref rid="B53-ijms-20-00584" ref-type="bibr">53</xref>]. Chronic abuse of cocaine is associated with left ventricular hypertrophy [<xref rid="B54-ijms-20-00584" ref-type="bibr">54</xref>]. In addition, catecholamine toxicity from chronic cocaine use was shown to be associated with myocarditis [<xref rid="B55-ijms-20-00584" ref-type="bibr">55</xref>], which was related to increased local immune reactions and myocardial necrosis [<xref rid="B56-ijms-20-00584" ref-type="bibr">56</xref>].</p></sec><sec id="sec2dot2dot2-ijms-20-00584"><title>2.2.2. Atherosclerosis</title><p>Coronary atherosclerosis often occurs in young cocaine users [<xref rid="B24-ijms-20-00584" ref-type="bibr">24</xref>,<xref rid="B57-ijms-20-00584" ref-type="bibr">57</xref>] or cocaine users with other cardiovascular diseases (e.g., MI) [<xref rid="B58-ijms-20-00584" ref-type="bibr">58</xref>]. According to previous studies, cocaine impairs nitric oxide release from endothelial cells [<xref rid="B59-ijms-20-00584" ref-type="bibr">59</xref>,<xref rid="B60-ijms-20-00584" ref-type="bibr">60</xref>]. In addition, cocaine increases levels of cell adhesion molecules (e.g., intracellular adhesion molecule-1 (ICAM-1), cluster of differentiation 54 (CD54), vascular cell adhesion molecule-1 (VCAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1)), low-density lipoprotein migration, and leukocyte migration in blood vessels [<xref rid="B61-ijms-20-00584" ref-type="bibr">61</xref>]. Moreover, intimal smooth muscle cells within the coronary artery wall increase [<xref rid="B24-ijms-20-00584" ref-type="bibr">24</xref>,<xref rid="B62-ijms-20-00584" ref-type="bibr">62</xref>], presumably leading to progression of atherosclerosis and potential sudden cardiac death [<xref rid="B63-ijms-20-00584" ref-type="bibr">63</xref>]. Based on immunological studies, mast cells in plaques may contribute to atherosclerosis, vasospasm, thrombosis, and sudden death [<xref rid="B57-ijms-20-00584" ref-type="bibr">57</xref>,<xref rid="B59-ijms-20-00584" ref-type="bibr">59</xref>,<xref rid="B64-ijms-20-00584" ref-type="bibr">64</xref>]. Briefly, proteolytic substances released from mast cells accelerate atherosclerosis by degrading and facilitating uptake of low-density lipoprotein cholesterol by macrophages [<xref rid="B65-ijms-20-00584" ref-type="bibr">65</xref>,<xref rid="B66-ijms-20-00584" ref-type="bibr">66</xref>]. Histamine released from mast cells increases endothelial permeability, which leads to leukocyte migration [<xref rid="B67-ijms-20-00584" ref-type="bibr">67</xref>]. As such, cocaine has complex effects on endothelial cell dysfunction, facilitates low-density lipoprotein and leukocyte migration, and increases intimal smooth muscle cells, all of which contribute to atherosclerosis in long-term users.</p></sec><sec id="sec2dot2dot3-ijms-20-00584"><title>2.2.3. Coronary Artery Diseases</title><p>Chronic cocaine use causes repetitive damages to the heart and vessels by interacting with norepinephrine transporters [<xref rid="B68-ijms-20-00584" ref-type="bibr">68</xref>]. Alpha-2 adrenergic receptors induce vasoconstriction of coronary arteries through contraction of vascular smooth muscle cells [<xref rid="B34-ijms-20-00584" ref-type="bibr">34</xref>], leading to prothrombotic effects caused by increased von Willebrand factor [<xref rid="B21-ijms-20-00584" ref-type="bibr">21</xref>]. Cocaine induces vasospasm through stimulation of adrenergic receptors on coronary arteries [<xref rid="B69-ijms-20-00584" ref-type="bibr">69</xref>]. Cocaine also promotes intracoronary thrombosis [<xref rid="B70-ijms-20-00584" ref-type="bibr">70</xref>,<xref rid="B71-ijms-20-00584" ref-type="bibr">71</xref>] through increased von Willebrand factor release, increased levels of endothelial tissue factor, an important factor in pathogenesis of acute coronary syndrome (ACS), decreased levels of tissue factor pathway inhibitor [<xref rid="B72-ijms-20-00584" ref-type="bibr">72</xref>], and accelerated atherosclerosis due to endothelial cell dysfunction [<xref rid="B60-ijms-20-00584" ref-type="bibr">60</xref>]. In addition, long-term use of cocaine induces endothelial injury, vascular fibrosis [<xref rid="B73-ijms-20-00584" ref-type="bibr">73</xref>,<xref rid="B74-ijms-20-00584" ref-type="bibr">74</xref>], and subsequent vessel wall weakening [<xref rid="B75-ijms-20-00584" ref-type="bibr">75</xref>], resulting in apoptosis of vascular smooth muscle cells and cystic medial necrosis [<xref rid="B76-ijms-20-00584" ref-type="bibr">76</xref>,<xref rid="B77-ijms-20-00584" ref-type="bibr">77</xref>]. According to previous reports, cocaine sometimes induces coronary and carotid aortic dissections [<xref rid="B78-ijms-20-00584" ref-type="bibr">78</xref>,<xref rid="B79-ijms-20-00584" ref-type="bibr">79</xref>,<xref rid="B80-ijms-20-00584" ref-type="bibr">80</xref>]. Thus, cocaine causes coronary artery diseases through multifactorial mechanisms including vasoconstriction, intracoronary thrombosis, and accelerated atherosclerosis.</p></sec></sec></sec><sec id="sec3-ijms-20-00584"><title>3. Cocaine Cardiotoxicity in Human Studies</title><p>Cocaine-induced cardiotoxicity can result in deleterious effects on the heart and vessels through multifactorial pathophysiological mechanisms, as described above. In this section, we focus on recent human studies published in the past 10 years, retrieved from the Medline database. <xref rid="ijms-20-00584-t001" ref-type="table">Table 1</xref> presents these studies that examined the association of cocaine use with both acute and chronic cardiovascular diseases and mortality.</p><sec id="sec3dot1-ijms-20-00584"><title>3.1. Acute Effects of Cocaine</title><p>A number of studies have reported a possible link between cocaine use and acute cardiovascular conditions such as acute hypertension, arrhythmia, coronary artery aneurysms (CAAs), and acute MI. Because the study populations and data sources varied across the studies, the findings of these studies should be interpreted carefully in the context of each individual study.</p><p>Kozor et al. [<xref rid="B81-ijms-20-00584" ref-type="bibr">81</xref>] in Australia compared blood pressure, aortic stiffness, and LV mass in cocaine users with those in cocaine non-users. The authors recruited 20 regular cocaine users aged 37 &#177; 7 years (85% male) and 20 control subjects aged 33 &#177; 7 years (95% male). This study defined regular cocaine use as using cocaine at least monthly during the year prior to when the study was conducted. The study findings showed that cocaine users had higher systolic blood pressure (134 &#177; 11 vs. 126 &#177; 11 mm Hg), increased aortic stiffness, and greater LV mass (124 &#177; 25 vs. 105 &#177; 16 g) compared with cocaine non-users.</p><p>In addition, Sharma et al. [<xref rid="B43-ijms-20-00584" ref-type="bibr">43</xref>] retrospectively reviewed electrocardiogram (ECG) recordings of cocaine-dependent subjects to examine cardiotoxicity of cocaine use. The ECGs were collected from 97 cocaine-dependent subjects aged 50 &#177; 4 years (86% male) in a comprehensive academic health center and 8513 cocaine-non-using subjects aged 52 &#177; 5 years (46% male) participating in the Atherosclerosis Risk in Communities (ARIC) study. The authors found significant effects of cocaine use on early repolarization (odds ratio (OR) = 4.92, 95% confidence interval (CI): 2.73&#8211;8.87), bradycardia (OR = 3.02, 95% CI: 1.95&#8211;4.66), severe bradycardia (OR = 5.11, 95% CI: 2.95&#8211;8.84), and heart rate (B weight = &#8722;5.84, 95% CI: &#8722;7.85 to &#8722;3.82). Recently, there was a case report of Mobitz type II atrioventricular (AV) block associated with cocaine use [<xref rid="B82-ijms-20-00584" ref-type="bibr">82</xref>]. This case occurred in a 55-year-old female who presented with chest pain after cocaine use.</p><p>Satran et al. [<xref rid="B83-ijms-20-00584" ref-type="bibr">83</xref>] investigated the prevalence of CAAs among cocaine users undergoing coronary angiography using a database from a medical center in the US. The study population included 112 patients with a history of cocaine use aged 44 &#177; 8 years (79% male) and 79 patients with no history of cocaine use aged 46 &#177; 5 years (61% male). Based on the finding that cocaine users had a significantly higher CAA compared with cocaine non-users (30.4% vs. 7.6%, respectively), the authors concluded that cocaine users were likely to be at increased risk of acute MI.</p><p>Several studies examined the association between cocaine use and MI. Gupta et al. [<xref rid="B84-ijms-20-00584" ref-type="bibr">84</xref>] examined the incidence of acute ST elevation myocardial infarction (STEMI), cardiogenic shock, multivessel CAD, and in-hospital mortality in the cocaine group (<italic toggle="yes">n</italic> = 924) compared with the non-cocaine group (<italic toggle="yes">n</italic> = 102,028) among patients admitted within 24 h of acute MI. This study used data from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines (ACTION Registry-GWTG) program. Compared with the non-cocaine group, the cocaine group was younger (average age: 50 (44&#8211;56) vs. 64 (54&#8211;76)), had a higher proportion of men (80% vs. 65%) and African-Americans (45% vs. 9%), and fewer traditional cardiovascular risk factors such as hypertension (65% vs. 71%), dyslipidemia (42% vs. 59%), previous coronary bypass (6% vs. 14%), and previous revascularization (24% vs. 31%). Gupta et al. [<xref rid="B84-ijms-20-00584" ref-type="bibr">84</xref>] found higher percentages of STEMI (46% vs. 40%) and cardiogenic shock (13% vs. 4%) in cocaine users although their percentage of multivessel CAD was lower (53% vs. 65%) compared with cocaine non-users. In-hospital mortality was similar between the two groups (OR = 1.00, 95% CI: 0.69&#8211;1.44). Another study conducted by Salihu et al. [<xref rid="B85-ijms-20-00584" ref-type="bibr">85</xref>] included pregnant women aged 13&#8211;49 years to examine the association of cocaine use with incidence of acute MI or cardiac arrest during pregnancy or childbirth. This retrospective study used data from January 2002 through December 2014 from the National Inpatient Sample (NIS), a large public inpatient database in the U.S. The study results showed that cocaine users (<italic toggle="yes">n</italic> = 153,608) were at higher risk for acute MI or cardiac arrest compared with drug non-users (<italic toggle="yes">n</italic> = 56,882,258), with adjusted OR of 1.83 (95% CI: 1.28&#8211;2.62). Some studies showed that the association between cocaine use and MI was affected by some confounders such as cardiac risk factors and risky behaviors. For example, Aslibekyan et al. [<xref rid="B86-ijms-20-00584" ref-type="bibr">86</xref>] conducted a retrospective study examining the prevalence of MI among civilian non-institutionalized US adults. Using data from the National Health and Nutrition Examination Survey (NHANES), their study included two different age groups for their study population: (a) individuals aged 18&#8211;59 years (<italic toggle="yes">n</italic> = 11,993, 46% male) and (b) those aged 18&#8211;45 years (<italic toggle="yes">n</italic> = 9337, 39% male). Although Aslibekyan et al. [<xref rid="B86-ijms-20-00584" ref-type="bibr">86</xref>] found no association between cocaine use and MI in the 18&#8211;59 age group, cocaine use of &gt;10 lifetime instances was significantly associated with MI in the 18&#8211;45 age group after adjusting for age (aged-adjusted OR = 4.60, 95% CI: 1.12&#8211;18.88). This association was affected by cardiac risk factors (e.g., smoking status, history of diabetes, hyperlipidemia, and hypertension) in the multivariate-adjusted model (OR = 3.84, 95% CI: 0.98&#8211;15.07). Another retrospective study by Gunja et al. [<xref rid="B87-ijms-20-00584" ref-type="bibr">87</xref>] examined the association of cocaine use with MI and 1-year all-cause mortality. The study included veterans with CAD who underwent coronary catheterization between October 2007 and September 2014 using the Veterans Affairs database. Compared with the non-cocaine group (<italic toggle="yes">n</italic> = 118,953), the cocaine group (<italic toggle="yes">n</italic> = 3082) was younger (median age: 58 vs. 65), more likely to be African-American (59% vs. 11%) and had fewer traditional cardiac risk factors. After adjusting for cardiac risk factors, cocaine use was significantly associated with MI (hazard ratio (HR) = 1.40, 95% CI: 1.07&#8211;1.83); however, this association became attenuated after controlling for risky behaviors in the sequential multivariable model (HR = 1.17, 95% CI: 0.87&#8211;1.56).</p><p>In summary, prior studies have reported that cocaine use was associated with acute cardiovascular conditions such as elevated blood pressure, (severe) bradycardia, CAAs, and acute MI. These findings are consistent with earlier studies documenting cocaine-related MI [<xref rid="B59-ijms-20-00584" ref-type="bibr">59</xref>,<xref rid="B98-ijms-20-00584" ref-type="bibr">98</xref>]. Of note, the studies in this review suggest that the association between cocaine use and MI might be confounded by cardiac risk factors or risky behaviors. Accordingly, the risk of MI among cocaine users needs to be understood in the context of risk factors and risky behaviors.</p></sec><sec id="sec3dot2-ijms-20-00584"><title>3.2. Chronic Effects of Cocaine</title><p>Several studies examined whether cocaine use was associated with chronic cardiovascular conditions such as cardiomyopathy (e.g., LV hypertrophy), subclinical atherosclerosis, and CAD. In this section, we present the characteristics of each study along with the study findings. We interpreted the results with consideration of study populations and data sources.</p><p>Maceira et al. [<xref rid="B45-ijms-20-00584" ref-type="bibr">45</xref>] found that cocaine abusers had increased LV end-systolic volume, LV mass index, and right ventricular (RV) end-systolic volume, with decreased LV ejection fraction and RV ejection fraction. The study participants were 94 cocaine abusers aged 37 &#177; 7 years (86% male) attending a rehabilitation clinic for the first time. They were compared with an age- and gender-matched healthy group. As previously mentioned, Kozor et al. [<xref rid="B81-ijms-20-00584" ref-type="bibr">81</xref>] also showed greater LV mass among regular cocaine users compared with cocaine nonusers.</p><p>Furthermore, several previous studies examined the association between cocaine use and CAD. The effects of cocaine on subclinical CAD were examined using different CAD surrogate markers [<xref rid="B84-ijms-20-00584" ref-type="bibr">84</xref>,<xref rid="B88-ijms-20-00584" ref-type="bibr">88</xref>,<xref rid="B89-ijms-20-00584" ref-type="bibr">89</xref>,<xref rid="B90-ijms-20-00584" ref-type="bibr">90</xref>,<xref rid="B91-ijms-20-00584" ref-type="bibr">91</xref>]. For example, Arora et al. [<xref rid="B88-ijms-20-00584" ref-type="bibr">88</xref>] examined the presence of subclinical CAD using carotid intima media thickness (CIMT) as a surrogate marker. This cross-sectional study included 33 Caucasian adults aged 37 &#177; 9 years who used cocaine (33% male). Their findings suggested no association between chronic cocaine use and subclinical CAD measured by CIMT. Another study conducted by Bamberg et al. examined the association of cocaine use with CAD and ACS using coronary computed tomography (CT) [<xref rid="B89-ijms-20-00584" ref-type="bibr">89</xref>]. The study subjects were patients who presented to the emergency department (ED) with acute chest pain. In this nested matched cohort study, there were 44 patients in the cocaine group aged 46 &#177; 7 years (86% male) and 132 patients in the age- and gender-matched non-cocaine group. The authors found no significant association between cocaine use and coronary stenosis, but found a significant association between cocaine use and ACS (OR = 5.79, 95% CI: 1.24&#8211;27.02). Chang et al. [<xref rid="B90-ijms-20-00584" ref-type="bibr">90</xref>] conducted another cross-sectional study that included patients who received coronary computerized tomographic angiography (CTA) for evaluation of CAD in the ED. The patients were at low- to intermediate-risk for ACS. Of these patients, cocaine users were aged 46&#177;6 years (<italic toggle="yes">n</italic> = 157, 58% male) while the non-cocaine group was aged 48 &#177; 9 years (<italic toggle="yes">n</italic> = 755, 40% male). Chang et al. [<xref rid="B90-ijms-20-00584" ref-type="bibr">90</xref>] found no association between repetitive cocaine use and coronary calcifications or between recent cocaine use and CAD. As noted previously, Gupta et al. [<xref rid="B84-ijms-20-00584" ref-type="bibr">84</xref>] investigated the incidence of multivessel CAD in addition to STEMI and cardiogenic shock between the cocaine group (<italic toggle="yes">n</italic> = 924) and the non-cocaine group (<italic toggle="yes">n</italic> = 102,028) among patients admitted within 24 h of acute MI. They found a lower percentage of multivessel CAD among cocaine users than cocaine nonusers (53% vs. 65%), although the percentages of STEMI (46% vs. 40%) and cardiogenic shock (13% vs. 4%) were higher. In contrast to these studies, a study by Lai et al. [<xref rid="B91-ijms-20-00584" ref-type="bibr">91</xref>] found a higher risk for subclinical CAD among cocaine users compared with cocaine non-users (propensity score-adjusted prevalence ratio (PR) = 1.27, 95% CI: 1.08&#8211;1.49). The subjects in the study by Lai et al. [<xref rid="B91-ijms-20-00584" ref-type="bibr">91</xref>] were African Americans aged 45 years (Interquartile range (IQR): 40&#8211;50), of whom 60% were males. Approximately 67% of the subjects were HIV-positive. In this cross-sectional study, subclinical CAD was defined by the presence of coronary artery calcium (CAC) detected by non-contrast CT and/or coronary plaque detected by contrast-enhanced CT angiography (CCTA). Chronic cocaine users were at significantly higher risk for the presence of CAC (propensity score-adjusted PR = 1.26, 95% CI: 1.05&#8211;1.52), any coronary stenosis (propensity score-adjusted PR = 1.30, 95% CI: 1.08&#8211;1.57), and calcified plaques (propensity score-adjusted PR = 1.37, 95% CI: 1.10&#8211;1.71), in addition to subclinical CAD. Another study conducted by Lucas et al. [<xref rid="B92-ijms-20-00584" ref-type="bibr">92</xref>] showed a significant association between cocaine use and carotid plaque formation. More than 90% of subjects in this study were African Americans. Cocaine non-users were aged 46 years (IQR: 41&#8211;53), and 67% were male. Past cocaine users were aged 51 years (IQR: 46&#8211;54), and 66% were male. Current cocaine users were aged 49 years (IQR: 45&#8211;52), and 75% were male. Of the study subjects, approximately 66% were HIV-positive. Compared with cocaine non-users, both past cocaine users and current users had approximately three-fold higher odds of having carotid plaques at baseline (OR = 3.3, 95% CI: 1.5&#8211;7.3 and OR = 2.7, 95% CI: 1.3&#8211;5.5, respectively).</p><p>In summary, cocaine was reported to be associated with high risk for cardiomyopathy characterized by LV hypertrophy [<xref rid="B45-ijms-20-00584" ref-type="bibr">45</xref>,<xref rid="B81-ijms-20-00584" ref-type="bibr">81</xref>] and ACS [<xref rid="B89-ijms-20-00584" ref-type="bibr">89</xref>]. In particular, one study found an approximately six-fold higher risk for ACS among cocaine users [<xref rid="B89-ijms-20-00584" ref-type="bibr">89</xref>]. However, studies have reported inconsistent findings regarding association between cocaine use and subclinical CAD. Some studies found no association of cocaine use with coronary calcifications [<xref rid="B88-ijms-20-00584" ref-type="bibr">88</xref>,<xref rid="B89-ijms-20-00584" ref-type="bibr">89</xref>,<xref rid="B90-ijms-20-00584" ref-type="bibr">90</xref>]. This result is consistent with findings in the Coronary Artery Risk Development in Young Adults (CARDIA) study which examined the association between cocaine exposure and prevalence of coronary calcification by including over 3000 participants [<xref rid="B99-ijms-20-00584" ref-type="bibr">99</xref>]. The CARDIA study reported no relationship between cocaine exposure and coronary calcium after adjusting for age, sex, ethnicity, socioeconomic status, family history, tobacco use, and alcohol use. However, Lai et al. [<xref rid="B91-ijms-20-00584" ref-type="bibr">91</xref>] reported that cocaine use was associated with subclinical coronary atherosclerosis. Lai et al. [<xref rid="B95-ijms-20-00584" ref-type="bibr">95</xref>,<xref rid="B96-ijms-20-00584" ref-type="bibr">96</xref>,<xref rid="B97-ijms-20-00584" ref-type="bibr">97</xref>] also showed this association in their earlier studies. Similarly, Lucas et al. [<xref rid="B92-ijms-20-00584" ref-type="bibr">92</xref>] found greater carotid plaque formation at baseline among cocaine users compared with cocaine nonusers. This variability in findings across studies regarding association between cocaine use and subclinical CAD might be explained by different CAD risk factor profiles of the study populations. The studies reporting cocaine-associated plaques included predominantly African American participants, of whom 40% to 100% were HIV-positive [<xref rid="B91-ijms-20-00584" ref-type="bibr">91</xref>,<xref rid="B92-ijms-20-00584" ref-type="bibr">92</xref>,<xref rid="B100-ijms-20-00584" ref-type="bibr">100</xref>,<xref rid="B101-ijms-20-00584" ref-type="bibr">101</xref>,<xref rid="B102-ijms-20-00584" ref-type="bibr">102</xref>]. In contrast, all other studies showing no association between cocaine use and coronary calcifications did not include any HIV-positive individuals [<xref rid="B84-ijms-20-00584" ref-type="bibr">84</xref>,<xref rid="B88-ijms-20-00584" ref-type="bibr">88</xref>,<xref rid="B89-ijms-20-00584" ref-type="bibr">89</xref>,<xref rid="B90-ijms-20-00584" ref-type="bibr">90</xref>]. It has been widely known that HIV infection is a risk factor for CAD. Therefore, the study subjects with HIV may have been at higher risk for development of CAD, as was pointed by Arora et al. [<xref rid="B88-ijms-20-00584" ref-type="bibr">88</xref>].</p></sec><sec id="sec3dot3-ijms-20-00584"><title>3.3. Effects of Cocaine on Mortality</title><p>Several studies estimated cardiovascular mortality among cocaine users. These studies have shown mixed results with regard to association of cocaine use with cardiovascular mortality. Some studies have reported higher risk for cardiovascular mortality among cocaine users compared with cocaine non-users. For example, DeFilippis et al. [<xref rid="B93-ijms-20-00584" ref-type="bibr">93</xref>] retrospectively analyzed records of patients with MI at &#8804;50 years of age between 2000 and 2016 to examine the risk of cocaine use for cardiovascular mortality and all-cause mortality. Patient data were obtained from two large academic medical centers in the US There were 99 individuals in the cocaine-group (mean age: 44 (40&#8211;46), 85% male) and 1873 individuals in the non-cocaine group (mean age: 45 (42&#8211;48), 80% male). The authors found significant associations of cocaine use with cardiovascular mortality (HR=2.32, 95% CI: 1.11-4.85) and all-cause mortality (HR = 1.91, 95% CI: 1.11&#8211;3.29). In Spain, Morentin et al. [<xref rid="B94-ijms-20-00584" ref-type="bibr">94</xref>] investigated the prevalence of recent cocaine use in individuals who had died by sudden cardiovascular death (SCVD) between January 2003 and December 2009 (<italic toggle="yes">n</italic> = 311). The mean age was 41 &#177; 7 years, and 82% were male. Individuals who had died by sudden deaths not due to cardiovascular diseases (SnoCVD) served as the control group (<italic toggle="yes">n</italic> = 126). The average age and percentage of males in the control group were 39 &#177; 7 years and 71%. The authors found that recent cocaine use was a significant risk factor for SCVD (OR = 4.10, 95% CI: 1.12&#8211;15.0). In contrast, Qureshi et al. [<xref rid="B95-ijms-20-00584" ref-type="bibr">95</xref>] found that regular cocaine use was not associated with cardiovascular mortality (relative risk (RR) = 0.6, 95% CI: 0.1&#8211;4.7). The study subjects in this retrospective study were civilian non-institutionalized US adults aged 18&#8211;45 in the NHANES dataset. The study included 7751 cocaine nonusers (mean age: 31 &#177; 8 years, 43% males) and 178 regular cocaine users (lifetime cocaine use &gt; 100 times) (mean age: 33 &#177; 7 years, 70% males). Although the study results showed a significant association between regular cocaine use and all-cause mortality (RR = 1.9, 95% CI: 1.2&#8211;3.0), regular cocaine use was not associated with cardiovascular mortality.</p><p>Prior studies examining the association of cocaine use with all-cause mortality have also reported inconsistent findings. In some studies, cocaine use was significantly associated with all-cause mortality. As mentioned previously, DeFilippis et al. [<xref rid="B93-ijms-20-00584" ref-type="bibr">93</xref>] and Qureshi et al. [<xref rid="B95-ijms-20-00584" ref-type="bibr">95</xref>] found an approximately two-fold higher all-cause mortality among cocaine users compared with cocaine nonusers. Similarly, Hser et al. [<xref rid="B96-ijms-20-00584" ref-type="bibr">96</xref>] found an elevated mortality risk associated with cocaine use relative to methamphetamine use (HR = 3.56, 95% CI: 1.95&#8211;6.48). The subjects in this study were women admitted to drug abuse treatment programs in the US between 2000 and 2002. Contrary to the findings of these studies, some studies have reported no significant association between in-hospital mortality and cocaine use [<xref rid="B84-ijms-20-00584" ref-type="bibr">84</xref>,<xref rid="B97-ijms-20-00584" ref-type="bibr">97</xref>]. Atoui et al. [<xref rid="B97-ijms-20-00584" ref-type="bibr">97</xref>] conducted a retrospective chart review of patients admitted with chest pain to a US-based hospital between July 2009 and June 2010. Of the study population with no risk factors for CAD, 54 were cocaine users (mean age = 44 &#177; 10 years, 59% males) and 372 were cocaine non-users (mean age = 43 &#177; 12 years, 49% males). The study results showed no significant differences in length of stay and in-hospital mortality between cocaine users and nonusers. Similarly, in the aforementioned study by Gupta et al. [<xref rid="B84-ijms-20-00584" ref-type="bibr">84</xref>] in-hospital mortality was not significantly different between the cocaine group and the non-cocaine group (OR = 1.00, 95% CI: 0.69&#8211;1.44). As mentioned previously, in the study by Gunja et al. [<xref rid="B87-ijms-20-00584" ref-type="bibr">87</xref>] cocaine use was initially found to be significantly associated with 1-year all-cause mortality after adjusting for cardiac risk factors and risky behaviors among veterans with CAD (HR = 1.22, 95% CI: 1.04&#8211;1.42) [<xref rid="B87-ijms-20-00584" ref-type="bibr">87</xref>]. However, after controlling for causal pathway conditions, mortality was no longer significantly associated with cocaine use (HR: 1.15, 95% CI: 0.99&#8211;1.33).</p><p>In summary, some prior studies have reported an association between cocaine use and cardiovascular or all-cause mortality [<xref rid="B93-ijms-20-00584" ref-type="bibr">93</xref>,<xref rid="B94-ijms-20-00584" ref-type="bibr">94</xref>,<xref rid="B96-ijms-20-00584" ref-type="bibr">96</xref>]. However, this association was not observed in other studies [<xref rid="B84-ijms-20-00584" ref-type="bibr">84</xref>,<xref rid="B97-ijms-20-00584" ref-type="bibr">97</xref>]. Variations in findings across studies may be driven by heterogeneity in patient characteristics (e.g., age), risky behaviors (e.g., smoking, alcohol, or other illicit drug use), and traditional risk factors (e.g., morbidities), all of which are predictors of mortality. Indeed, the study by Gunja et al. [<xref rid="B87-ijms-20-00584" ref-type="bibr">87</xref>] showed how the association between cocaine use and mortality was confounded by these factors. In their study, cocaine was initially found to be associated with increased all-cause mortality. However, this association was no longer observed after controlling for causal pathway conditions such as congestive heart failure, cardiogenic shock, dialysis, depression, anxiety, ACS, and clinical status. This finding suggests that the effects of cocaine on mortality are largely dependent on individual clinical risk factors. Notably, mortality risk was not significantly higher among cocaine users if the cocaine users had fewer risk factors compared with cocaine nonusers. For example, subjects in the studies performed by Atoui et al. [<xref rid="B97-ijms-20-00584" ref-type="bibr">97</xref>] and Gupta et al. [<xref rid="B84-ijms-20-00584" ref-type="bibr">84</xref>] were individuals at low risk for CVD and young adults with few CV risk factors, respectively. Both studies found no association between cocaine use and mortality. In contrast, the subjects in studies reporting an association between cocaine use and mortality were at higher risk. The presence of risk factors is likely to augment the risk of mortality following cocaine use. Furthermore, frequency of cocaine use could be an important factor affecting mortality risk among cocaine users. As observed in the study by Qureshi et al., all-cause mortality was about two times higher among regular cocaine users (lifetime cocaine use &gt; 100 times) compared with cocaine nonusers [<xref rid="B95-ijms-20-00584" ref-type="bibr">95</xref>]. However, all cause-mortality of infrequent cocaine users (lifetime cocaine use: 1&#8211;10 times) or frequent cocaine users (lifetime cocaine use &gt; 10 times) was not significantly different from that of cocaine nonusers in this study.</p></sec></sec><sec id="sec4-ijms-20-00584"><title>4. Cocaine and Nutrition</title><p>Cocaine use/abuse often affects food intake behavior and suppresses appetite, which may lead to the disruption of metabolic and neuroendocrine regulation. In addition, cocaine-induced malnutrition may decrease levels of neurotransmitters, and alter amino acid absorption and utilization. As such, chronic exposure to cocaine can result in an increased risk of health conditions such as hypertension, body weight problems, diabetes, and metabolic syndrome.</p><p>Cocaine affects appetite and body weight through multifactorial mechanisms. As mentioned previously, cocaine inhibits the reuptake of dopamine by interacting with the dopamine transporter, resulting in increased levels of dopamine in the central nervous system. Subsequently, changes in dopamine levels affect eating behavior and body weight [<xref rid="B103-ijms-20-00584" ref-type="bibr">103</xref>,<xref rid="B104-ijms-20-00584" ref-type="bibr">104</xref>,<xref rid="B105-ijms-20-00584" ref-type="bibr">105</xref>]. Increased dopaminergic neurotransmission suppresses overall food intake whereas it increases fat-rich food intake [<xref rid="B106-ijms-20-00584" ref-type="bibr">106</xref>]. In addition, cocaine blocks the reuptake of serotonin by interacting with the serotonin transporter, inducing leptin-dependent anorexic effect [<xref rid="B107-ijms-20-00584" ref-type="bibr">107</xref>,<xref rid="B108-ijms-20-00584" ref-type="bibr">108</xref>]. Prior studies demonstrated that cocaine also upregulated neuromodulators such as cocaine- and amphetamine-regulated transcript (CART), which plays an important role in regulating food intake, maintaining body weight, and in endocrine and cardiovascular functions [<xref rid="B109-ijms-20-00584" ref-type="bibr">109</xref>,<xref rid="B110-ijms-20-00584" ref-type="bibr">110</xref>]. Overexpression of CART has been reported to decrease food intake and change lipid metabolism related to fat storage [<xref rid="B111-ijms-20-00584" ref-type="bibr">111</xref>,<xref rid="B112-ijms-20-00584" ref-type="bibr">112</xref>].</p><p>In accordance with these mechanisms, several pre-clinical studies have shown the effects of cocaine on food consumption and the nutritional status in animals [<xref rid="B113-ijms-20-00584" ref-type="bibr">113</xref>,<xref rid="B114-ijms-20-00584" ref-type="bibr">114</xref>,<xref rid="B115-ijms-20-00584" ref-type="bibr">115</xref>]. For example, Balopole et al. [<xref rid="B113-ijms-20-00584" ref-type="bibr">113</xref>] reported a decrease in food intake after cocaine administration to rats (10, 15, and 25 mg/kg). They found that the cocaine-induced anorexia was transient and dose-dependent. After an hour of anorexic effect, it was shown that animals overconsumed foods. Therefore, total food intake was not significantly different between cocaine- and saline-exposed rats. Another study examined the effects of cocaine on the milk intake and body weight in rats [<xref rid="B114-ijms-20-00584" ref-type="bibr">114</xref>]. Findings of this study suggested that cocaine disrupted ingestion primarily by interfering with the appetitive phase of feeding behavior (orientation and approach to food) rather than the consummatory phase (ingestion of food). A study by Church et al. [<xref rid="B115-ijms-20-00584" ref-type="bibr">115</xref>] examined the effects of prenatal cocaine exposure on maternal/fetal toxicity in animals. Cocaine treatments in rats (20, 30, 40, and 50 mg/kg) resulted in significant reductions in the maternal weight gain and food consumption in a dose-dependent manner. Undernutrition led to a significant reduction in fetal weight. However, maternal water consumption was significantly increased in the cocaine-exposed animals possibly because of the increased locomotor activity and diuretic effect. Furthermore, cocaine provoked diarrhea in some of animals that received high doses, suggesting that cocaine, as a gastrointestinal irritant, might cause malabsorption and loss of electrolytes and nutrients, which ultimately can lead to malnutrition.</p><p>Human studies have also shown cocaine&#8217;s anorexigenic effects and the resulting weight reduction in cocaine users [<xref rid="B116-ijms-20-00584" ref-type="bibr">116</xref>,<xref rid="B117-ijms-20-00584" ref-type="bibr">117</xref>]. Low caloric intake, together with abnormal metabolic and gastrointestinal functions, can lead to malnutrition among cocaine users [<xref rid="B118-ijms-20-00584" ref-type="bibr">118</xref>]. For example, Escobar et al. [<xref rid="B119-ijms-20-00584" ref-type="bibr">119</xref>] found that hemoglobin and hematocrit levels in cocaine users were below normal, indicating protein-energy malnutrition and anemia. As the authors pointed out, anemia in this population might be associated with a diet poor in micronutrients (e.g., iron), inadequate protein consumption, and clinical issues such as decreased intrinsic factor secretion, intestinal perforations, and bacterial or infectious diseases. Indeed, three cases were reported where patients required surgery for their intestinal perforations after cocaine use [<xref rid="B120-ijms-20-00584" ref-type="bibr">120</xref>]. Cocaine led to mesenteric vasoconstriction and focal tissue ischemia by blocking the reuptake of norepinephrine, which might lead to intestinal perforations. Cocaine users in the study by Escobar et al. were also found to have altered lipid and glucose profiles, with low levels of high density lipoprotein (HDL) cholesterol and high levels of triglycerides, LDL cholesterol, total cholesterol, and glucose. These findings suggested that cocaine users might be at a high risk for metabolic and cardiovascular problems. Of note, cocaine users did not experience weight gain despite a compensatory increase in fat consumption following the cocaine-induced anorexia [<xref rid="B117-ijms-20-00584" ref-type="bibr">117</xref>]. However, the cessation of cocaine use resulted in weight gain [<xref rid="B117-ijms-20-00584" ref-type="bibr">117</xref>,<xref rid="B121-ijms-20-00584" ref-type="bibr">121</xref>]. In a study by Ersche et al., cocaine users consumed significantly more fatty foods and carbohydrates compared with cocaine nonusers, but there was no concomitant weight increase in the cocaine group [<xref rid="B117-ijms-20-00584" ref-type="bibr">117</xref>]. The authors suggested that an imbalance between fat intake and storage could lead to weight gain among cocaine users when they stop using cocaine. This imbalance might result from metabolic alterations from repeated cocaine use. It is well-known that weight gain increases the risk of cardio-metabolic disorders such as diabetes and cardiovascular conditions [<xref rid="B122-ijms-20-00584" ref-type="bibr">122</xref>]. Therefore, weight control, as a means to prevent and lessen cardiovascular diseases, has profound implications during cocaine abstinence.</p><p>In summary, cocaine use affects eating behavior and suppresses appetite, leading to malnutrition and anorexia through disruption of the metabolic process and neuroendocrine regulation. Also, cocaine uptake in the body can lead to mesenteric vasoconstriction and focal tissue ischemia, and alter lipid as well as glucose profiles, presumably resulting in increased risk for metabolic and cardiovascular problems in cocaine users. Notably, the cessation of cocaine use causes sudden/excess weight gain during the recovery period/process, leading to increased cardiovascular and cardio-metabolic risks. As such, cocaine-induced changes in food intake patterns and the metabolic process can lead to cardiovascular complications during addiction as well as cessation periods.</p></sec><sec sec-type="conclusions" id="sec5-ijms-20-00584"><title>5. Conclusions</title><p>Cocaine use/abuse has been known to make changes in nutrient status and metabolism, which can result in an increased risk of long-term health conditions including eating disorders, metabolic syndrome, and psychological abnormalities. In this review, we focus the deleterious acute and chronic effects of cocaine use particularly on cardiovascular outcomes. We summarized the pathophysiological mechanisms of cocaine on cardiovascular health, which were multifactorial and complex. Compared to chronic effects, acute effects of cocaine have been well-characterized in previous studies. Use of cocaine, a potent cardiovascular stimulant, has been associated with electrocardiographic abnormalities, elevated blood pressure, arrhythmia, and acute MI. The risk of MI among cocaine users was particularly influenced by individuals&#8217; cardiac risk factors and risky behaviors. Cocaine use can lead to acute conditions in a multifactorial fashion, for example, by blocking sodium/potassium channels in the heart and enhancing coronary artery spasm/vasoconstriction in vessels. In contrast, chronic effects of cocaine are difficult to determine as evidenced by inconsistent findings across previous studies. Some studies have reported an association of chronic cocaine use with coronary atherosclerosis using coronary calcification as a marker. Conversely, other studies have demonstrated no association between chronic cocaine use and coronary calcification. Of note, the subjects included in studies showing this association were at higher risk for CAD compared with those in the studies that reported no association. Therefore, chronic effects of cocaine may have been more prominent among those with higher CAD risk factor profiles. Contributions of cocaine to chronic conditions were also multifaceted. Long-term exposure to cocaine can exert chronic effects, for example, on the heart through non-ischemic myocardial depression and vessels by inducing endothelial cell injury and intracoronary thrombosis. Furthermore, prior studies suggested that risky behaviors, risk factors for CVD, and frequency of cocaine use may contribute to association between cocaine use and mortality. To evaluate the effects of long-term cocaine use on atherosclerosis and mortality more precisely, large, well-designed longitudinal studies are required with subjects from both low and high-risk populations. &#946;-blocker therapy has often been suggested for cocaine users, in particular, for those with cocaine-associated heart failure. Studies have shown &#946;-blockers lowered blood pressure, improved LV ejection fraction, and reduced the incidence of MI and mortality among cocaine users [<xref rid="B123-ijms-20-00584" ref-type="bibr">123</xref>,<xref rid="B124-ijms-20-00584" ref-type="bibr">124</xref>,<xref rid="B125-ijms-20-00584" ref-type="bibr">125</xref>]. Understanding the multifactorial pathophysiological mechanisms of cocaine could help clinicians recognize the various symptoms after cocaine use/abuse and improve treatment of patients with either acute or chronic symptoms. The various deleterious CV outcomes resulting from cocaine use highlight the need for education regarding adverse cardiac effects of cocaine use, and access to effective interventions for cocaine abusers. Concurrently, alterations in lifestyle and behaviors (e.g., alcohol abuse or tobacco use) are also important for reducing the harmful adverse cardiac effects that these behavioral factors contribute to among cocaine users.</p></sec></body><back><notes><title>Author contributions</title><p>Both S.T.K. and T.P. conceptualized and designed the study, extracted and interpreted the data, drafted the manuscript, and approved the final version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-20-00584"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cornish</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>C.P.</given-names></name></person-group><article-title>Crack cocaine abuse: An epidemic with many public health consequences</article-title><source>Annu. Rev. Public Health</source><year>1996</year><volume>17</volume><fpage>259</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1146/annurev.pu.17.050196.001355</pub-id><pub-id pub-id-type="pmid">8724227</pub-id></element-citation></ref><ref id="B2-ijms-20-00584"><label>2.</label><element-citation publication-type="web"><article-title>World Drug Report 2018</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_3_DRUG_MARKETS.pdf">https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_3_DRUG_MARKETS.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2018-10-29">(accessed on 29 October 2018)</date-in-citation></element-citation></ref><ref id="B3-ijms-20-00584"><label>3.</label><element-citation publication-type="gov"><article-title>Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf">https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2018-10-29">(accessed on 29 October 2018)</date-in-citation></element-citation></ref><ref id="B4-ijms-20-00584"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Egred</surname><given-names>M.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>G.K.</given-names></name></person-group><article-title>Cocaine and the heart</article-title><source>Postgrad. Med. J.</source><year>2005</year><volume>81</volume><fpage>568</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1136/pgmj.2004.028571</pub-id><pub-id pub-id-type="pmid">16143686</pub-id><pub-id pub-id-type="pmcid">PMC1743343</pub-id></element-citation></ref><ref id="B5-ijms-20-00584"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Giorgi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fabbian</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pala</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bonetti</surname><given-names>F.</given-names></name><name name-style="western"><surname>Babini</surname><given-names>I.</given-names></name><name name-style="western"><surname>Bagnaresi</surname><given-names>I.</given-names></name><name name-style="western"><surname>Manfredini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Portaluppi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mikhailidis</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Manfredini</surname><given-names>R.</given-names></name></person-group><article-title>Cocaine and acute vascular diseases</article-title><source>Curr. Drug Abuse Rev.</source><year>2012</year><volume>5</volume><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.2174/1874473711205020129</pub-id><pub-id pub-id-type="pmid">22455504</pub-id></element-citation></ref><ref id="B6-ijms-20-00584"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lange</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Hillis</surname><given-names>L.D.</given-names></name></person-group><article-title>Cardiovascular complications of cocaine use</article-title><source>N. Engl. J. Med.</source><year>2001</year><volume>345</volume><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1056/NEJM200108023450507</pub-id><pub-id pub-id-type="pmid">11484693</pub-id></element-citation></ref><ref id="B7-ijms-20-00584"><label>7.</label><element-citation publication-type="gov"><article-title>Trends in Substance Use Disorders among Adults Aged 18 or Older</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.samhsa.gov/data/sites/default/files/report_2790/ShortReport-2790.html">https://www.samhsa.gov/data/sites/default/files/report_2790/ShortReport-2790.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2018-11-11">(accessed on 11 November 2018)</date-in-citation></element-citation></ref><ref id="B8-ijms-20-00584"><label>8.</label><element-citation publication-type="gov"><article-title>Drug Abuse Warning Network Trends Tables, 2011 Update</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/rpts/DAWN2k11-Trend-Tables.htm">https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/rpts/DAWN2k11-Trend-Tables.htm</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2018-11-11">(accessed on 11 November 2018)</date-in-citation></element-citation></ref><ref id="B9-ijms-20-00584"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vongpatanasin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Mansour</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chavoshan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Arbique</surname><given-names>D.</given-names></name><name name-style="western"><surname>Victor</surname><given-names>R.G.</given-names></name></person-group><article-title>Cocaine stimulates the human cardiovascular system via a central mechanism of action</article-title><source>Circulation</source><year>1999</year><volume>100</volume><fpage>497</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.100.5.497</pub-id><pub-id pub-id-type="pmid">10430763</pub-id></element-citation></ref><ref id="B10-ijms-20-00584"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howell</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>F.I.</given-names></name><name name-style="western"><surname>Votaw</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Kimmel</surname><given-names>H.L.</given-names></name></person-group><article-title>Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2007</year><volume>320</volume><fpage>757</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1124/jpet.106.108324</pub-id><pub-id pub-id-type="pmid">17105829</pub-id></element-citation></ref><ref id="B11-ijms-20-00584"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwartz</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Rezkalla</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kloner</surname><given-names>R.A.</given-names></name></person-group><article-title>Cardiovascular effects of cocaine</article-title><source>Circulation</source><year>2010</year><volume>122</volume><fpage>2558</fpage><lpage>2569</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.940569</pub-id><pub-id pub-id-type="pmid">21156654</pub-id></element-citation></ref><ref id="B12-ijms-20-00584"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pennings</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Leccese</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Wolff</surname><given-names>F.A.</given-names></name></person-group><article-title>Effects of concurrent use of alcohol and cocaine</article-title><source>Addiction</source><year>2002</year><volume>97</volume><fpage>773</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1046/j.1360-0443.2002.00158.x</pub-id><pub-id pub-id-type="pmid">12133112</pub-id></element-citation></ref><ref id="B13-ijms-20-00584"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rezkalla</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Kloner</surname><given-names>R.A.</given-names></name></person-group><article-title>Cocaine-induced acute myocardial infarction</article-title><source>Clin. Med. Res.</source><year>2007</year><volume>5</volume><fpage>172</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.3121/cmr.2007.759</pub-id><pub-id pub-id-type="pmid">18056026</pub-id><pub-id pub-id-type="pmcid">PMC2111405</pub-id></element-citation></ref><ref id="B14-ijms-20-00584"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davies</surname><given-names>O.</given-names></name><name name-style="western"><surname>Ajayeoba</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kurian</surname><given-names>D.</given-names></name></person-group><article-title>Coronary artery spasm: An often overlooked diagnosis</article-title><source>Niger. Med. J.</source><year>2014</year><volume>55</volume><fpage>356</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.4103/0300-1652.137231</pub-id><pub-id pub-id-type="pmid">25114375</pub-id><pub-id pub-id-type="pmcid">PMC4124553</pub-id></element-citation></ref><ref id="B15-ijms-20-00584"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Talarico</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Crosta</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Giannico</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Summaria</surname><given-names>F.</given-names></name><name name-style="western"><surname>Calo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Patrizi</surname><given-names>R.</given-names></name></person-group><article-title>Cocaine and coronary artery diseases: A systematic review of the literature</article-title><source>J. Cardiovasc. Med.</source><year>2017</year><volume>18</volume><fpage>291</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.2459/JCM.0000000000000511</pub-id><pub-id pub-id-type="pmid">28306693</pub-id></element-citation></ref><ref id="B16-ijms-20-00584"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilbert-Lampen</surname><given-names>U.</given-names></name><name name-style="western"><surname>Seliger</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zilker</surname><given-names>T.</given-names></name><name name-style="western"><surname>Arendt</surname><given-names>R.M.</given-names></name></person-group><article-title>Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: Reversal by coincubation with sigma-receptor antagonists</article-title><source>Circulation</source><year>1998</year><volume>98</volume><fpage>385</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.98.5.385</pub-id><pub-id pub-id-type="pmid">9714087</pub-id></element-citation></ref><ref id="B17-ijms-20-00584"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Togna</surname><given-names>G.I.</given-names></name><name name-style="western"><surname>Graziani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Russo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Caprino</surname><given-names>L.</given-names></name></person-group><article-title>Cocaine toxic effect on endothelium-dependent vasorelaxation: An in vitro study on rabbit aorta</article-title><source>Toxicol. Lett.</source><year>2001</year><volume>123</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/S0378-4274(01)00379-4</pub-id><pub-id pub-id-type="pmid">11514104</pub-id></element-citation></ref><ref id="B18-ijms-20-00584"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Arruda</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Dunea</surname><given-names>G.</given-names></name></person-group><article-title>Role of nitric oxide in cocaine-induced acute hypertension</article-title><source>Am. J. Hypertens.</source><year>1998</year><volume>11</volume><fpage>708</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1016/S0895-7061(98)00041-7</pub-id><pub-id pub-id-type="pmid">9657630</pub-id></element-citation></ref><ref id="B19-ijms-20-00584"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perreault</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>K.G.</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>J.P.</given-names></name></person-group><article-title>Effects of cocaine on intracellular calcium handling in cardiac and vascular smooth muscle</article-title><source>NIDA Res. Monogr.</source><year>1991</year><volume>108</volume><fpage>139</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">1749409</pub-id></element-citation></ref><ref id="B20-ijms-20-00584"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scholz</surname><given-names>A.</given-names></name></person-group><article-title>Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels</article-title><source>Br. J. Anaesth.</source><year>2002</year><volume>89</volume><fpage>52</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1093/bja/aef163</pub-id><pub-id pub-id-type="pmid">12173241</pub-id></element-citation></ref><ref id="B21-ijms-20-00584"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Sholar</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Mendelson</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Lukas</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Renshaw</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Lewandrowski</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Apple</surname><given-names>F.S.</given-names></name><name name-style="western"><surname>Stec</surname><given-names>J.J.</given-names></name><etal/></person-group><article-title>Cocaine-induced erythrocytosis and increase in von Willebrand factor: Evidence for drug-related blood doping and prothrombotic effects</article-title><source>Arch. Intern. Med.</source><year>1999</year><volume>159</volume><fpage>1925</fpage><lpage>1929</lpage><pub-id pub-id-type="doi">10.1001/archinte.159.16.1925</pub-id><pub-id pub-id-type="pmid">10493323</pub-id></element-citation></ref><ref id="B22-ijms-20-00584"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crumb</surname><given-names>W.J.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Clarkson</surname><given-names>C.W.</given-names></name></person-group><article-title>Characterization of cocaine-induced block of cardiac sodium channels</article-title><source>Biophys. J.</source><year>1990</year><volume>57</volume><fpage>589</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(90)82574-1</pub-id><pub-id pub-id-type="pmid">2155033</pub-id><pub-id pub-id-type="pmcid">PMC1280752</pub-id></element-citation></ref><ref id="B23-ijms-20-00584"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoffman</surname><given-names>R.S.</given-names></name></person-group><article-title>Treatment of patients with cocaine-induced arrhythmias: Bringing the bench to the bedside</article-title><source>Br. J. Clin. Pharmacol.</source><year>2010</year><volume>69</volume><fpage>448</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.2010.03632.x</pub-id><pub-id pub-id-type="pmid">20573080</pub-id><pub-id pub-id-type="pmcid">PMC2856045</pub-id></element-citation></ref><ref id="B24-ijms-20-00584"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Restieaux</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Low</surname><given-names>C.J.</given-names></name></person-group><article-title>Myocardial infarction in young people with normal coronary arteries</article-title><source>Heart</source><year>1998</year><volume>79</volume><fpage>191</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1136/hrt.79.2.191</pub-id><pub-id pub-id-type="pmid">9538315</pub-id><pub-id pub-id-type="pmcid">PMC1728590</pub-id></element-citation></ref><ref id="B25-ijms-20-00584"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y.Q.</given-names></name><name name-style="western"><surname>Crumb</surname><given-names>W.J.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Clarkson</surname><given-names>C.W.</given-names></name></person-group><article-title>Cocaethylene, a metabolite of cocaine and ethanol, is a potent blocker of cardiac sodium channels</article-title><source>J. Pharmacol. Exp. Ther.</source><year>1994</year><volume>271</volume><fpage>319</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">7965731</pub-id></element-citation></ref><ref id="B26-ijms-20-00584"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldstein</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>DesLauriers</surname><given-names>C.</given-names></name><name name-style="western"><surname>Burda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Johnson-Arbor</surname><given-names>K.</given-names></name></person-group><article-title>Cocaine: History, social implications, and toxicity: A review</article-title><source>Semin. Diagn. Pathol.</source><year>2009</year><volume>26</volume><fpage>10</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1053/j.semdp.2008.12.001</pub-id><pub-id pub-id-type="pmid">19292024</pub-id></element-citation></ref><ref id="B27-ijms-20-00584"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Leary</surname><given-names>M.E.</given-names></name></person-group><article-title>Inhibition of HERG potassium channels by cocaethylene: A metabolite of cocaine and ethanol</article-title><source>Cardiovasc. Res.</source><year>2002</year><volume>53</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/S0008-6363(01)00458-8</pub-id><pub-id pub-id-type="pmid">11744013</pub-id></element-citation></ref><ref id="B28-ijms-20-00584"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>S.</given-names></name><name name-style="western"><surname>Crumb</surname><given-names>W.J.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Carlton</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Clarkson</surname><given-names>C.W.</given-names></name></person-group><article-title>Effects of cocaine and its major metabolites on the HERG-encoded potassium channel</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2001</year><volume>299</volume><fpage>220</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">11561083</pub-id></element-citation></ref><ref id="B29-ijms-20-00584"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Leary</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Hancox</surname><given-names>J.C.</given-names></name></person-group><article-title>Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias</article-title><source>Br. J. Clin. Pharmacol.</source><year>2010</year><volume>69</volume><fpage>427</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.2010.03629.x</pub-id><pub-id pub-id-type="pmid">20573078</pub-id><pub-id pub-id-type="pmcid">PMC2856043</pub-id></element-citation></ref><ref id="B30-ijms-20-00584"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crandall</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Vongpatanasin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Victor</surname><given-names>R.G.</given-names></name></person-group><article-title>Mechanism of cocaine-induced hyperthermia in humans</article-title><source>Ann. Intern. Med.</source><year>2002</year><volume>136</volume><fpage>785</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-136-11-200206040-00006</pub-id><pub-id pub-id-type="pmid">12044126</pub-id></element-citation></ref><ref id="B31-ijms-20-00584"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Catravas</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Waters</surname><given-names>I.W.</given-names></name></person-group><article-title>Acute cocaine intoxication in the conscious dog: Studies on the mechanism of lethality</article-title><source>J. Pharmacol. Exp. Ther.</source><year>1981</year><volume>217</volume><fpage>350</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">7229977</pub-id></element-citation></ref><ref id="B32-ijms-20-00584"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bachi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mani</surname><given-names>V.</given-names></name><name name-style="western"><surname>Jeyachandran</surname><given-names>D.</given-names></name><name name-style="western"><surname>Fayad</surname><given-names>Z.A.</given-names></name><name name-style="western"><surname>Goldstein</surname><given-names>R.Z.</given-names></name><name name-style="western"><surname>Alia-Klein</surname><given-names>N.</given-names></name></person-group><article-title>Vascular disease in cocaine addiction</article-title><source>Atherosclerosis</source><year>2017</year><volume>262</volume><fpage>154</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2017.03.019</pub-id><pub-id pub-id-type="pmid">28363516</pub-id><pub-id pub-id-type="pmcid">PMC5757372</pub-id></element-citation></ref><ref id="B33-ijms-20-00584"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mouhaffel</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Madu</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Satmary</surname><given-names>W.A.</given-names></name><name name-style="western"><surname>Fraker</surname><given-names>T.D.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Cardiovascular complications of cocaine</article-title><source>Chest</source><year>1995</year><volume>107</volume><fpage>1426</fpage><lpage>1434</lpage><pub-id pub-id-type="doi">10.1378/chest.107.5.1426</pub-id><pub-id pub-id-type="pmid">7750342</pub-id></element-citation></ref><ref id="B34-ijms-20-00584"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lange</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Cigarroa</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Yancy</surname><given-names>C.W.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Willard</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Popma</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Sills</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>McBride</surname><given-names>W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Hillis</surname><given-names>L.D.</given-names></name></person-group><article-title>Cocaine-induced coronary-artery vasoconstriction</article-title><source>N. Engl. J. Med.</source><year>1989</year><volume>321</volume><fpage>1557</fpage><lpage>1562</lpage><pub-id pub-id-type="doi">10.1056/NEJM198912073212301</pub-id><pub-id pub-id-type="pmid">2573838</pub-id></element-citation></ref><ref id="B35-ijms-20-00584"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandoval</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Thordsen</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Apple</surname><given-names>F.S.</given-names></name></person-group><article-title>Supply/demand type 2 myocardial infarction: Should we be paying more attention?</article-title><source>J. Am. Coll. Cardiol.</source><year>2014</year><volume>63</volume><fpage>2079</fpage><lpage>2087</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2014.02.541</pub-id><pub-id pub-id-type="pmid">24632278</pub-id></element-citation></ref><ref id="B36-ijms-20-00584"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pradhan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mondal</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chandra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M.</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>K.C.</given-names></name></person-group><article-title>Molecular analysis of cocaine-induced endothelial dysfunction: Role of endothelin-1 and nitric oxide</article-title><source>Cardiovasc. Toxicol.</source><year>2008</year><volume>8</volume><fpage>161</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1007/s12012-008-9025-z</pub-id><pub-id pub-id-type="pmid">18813882</pub-id></element-citation></ref><ref id="B37-ijms-20-00584"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bohm</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pernow</surname><given-names>J.</given-names></name></person-group><article-title>The importance of endothelin-1 for vascular dysfunction in cardiovascular disease</article-title><source>Cardiovasc. Res.</source><year>2007</year><volume>76</volume><fpage>8</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2007.06.004</pub-id><pub-id pub-id-type="pmid">17617392</pub-id></element-citation></ref><ref id="B38-ijms-20-00584"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Previtali</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bucciarelli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Passamonti</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Martinelli</surname><given-names>I.</given-names></name></person-group><article-title>Risk factors for venous and arterial thrombosis</article-title><source>Blood Transfus.</source><year>2011</year><volume>9</volume><fpage>120</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">21084000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2450/2010.0066-10</pub-id><pub-id pub-id-type="pmcid">PMC3096855</pub-id></element-citation></ref><ref id="B39-ijms-20-00584"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Badimon</surname><given-names>L.</given-names></name><name name-style="western"><surname>Padro</surname><given-names>T.</given-names></name><name name-style="western"><surname>Vilahur</surname><given-names>G.</given-names></name></person-group><article-title>Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease</article-title><source>Eur. Heart J. Acute Cardiovasc. Care</source><year>2012</year><volume>1</volume><fpage>60</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1177/2048872612441582</pub-id><pub-id pub-id-type="pmid">24062891</pub-id><pub-id pub-id-type="pmcid">PMC3760546</pub-id></element-citation></ref><ref id="B40-ijms-20-00584"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wright</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Goff</surname><given-names>T.</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Elworthy</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ghoneim</surname><given-names>S.</given-names></name></person-group><article-title>Cocaine and thrombosis: A narrative systematic review of clinical and in-vivo studies</article-title><source>Subst. Abuse Treat. Prev. Policy</source><year>2007</year><volume>2</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/1747-597X-2-27</pub-id><pub-id pub-id-type="pmid">17880705</pub-id><pub-id pub-id-type="pmcid">PMC2042971</pub-id></element-citation></ref><ref id="B41-ijms-20-00584"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalogeris</surname><given-names>T.</given-names></name><name name-style="western"><surname>Baines</surname><given-names>C.P.</given-names></name><name name-style="western"><surname>Krenz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Korthuis</surname><given-names>R.J.</given-names></name></person-group><article-title>Cell biology of ischemia/reperfusion injury</article-title><source>Int. Rev. Cell Mol. Biol.</source><year>2012</year><volume>298</volume><fpage>229</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">22878108</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/B978-0-12-394309-5.00006-7</pub-id><pub-id pub-id-type="pmcid">PMC3904795</pub-id></element-citation></ref><ref id="B42-ijms-20-00584"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graziani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Antonilli</surname><given-names>L.</given-names></name><name name-style="western"><surname>Togna</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Grassi</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Badiani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Saso</surname><given-names>L.</given-names></name></person-group><article-title>Cardiovascular and hepatic toxicity of cocaine: Potential beneficial effects of modulators of oxidative stress</article-title><source>Oxid. Med. Cell Longev.</source><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/8408479</pub-id><pub-id pub-id-type="pmcid">PMC4707355</pub-id><pub-id pub-id-type="pmid">26823954</pub-id></element-citation></ref><ref id="B43-ijms-20-00584"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores</surname><given-names>E.D.</given-names></name><name name-style="western"><surname>Lange</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Cigarroa</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Hillis</surname><given-names>L.D.</given-names></name></person-group><article-title>Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: Enhanced vasoconstriction at sites of significant stenoses</article-title><source>J. Am. Coll. Cardiol.</source><year>1990</year><volume>16</volume><fpage>74</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/0735-1097(90)90459-3</pub-id><pub-id pub-id-type="pmid">2358608</pub-id></element-citation></ref><ref id="B44-ijms-20-00584"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Hueter</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>G.J.</given-names></name></person-group><article-title>Acute myocardial infarction following cocaine abuse in a young woman with normal coronary arteries</article-title><source>JAMA</source><year>1985</year><volume>254</volume><fpage>95</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1001/jama.1985.03360010101036</pub-id><pub-id pub-id-type="pmid">3999356</pub-id></element-citation></ref><ref id="B45-ijms-20-00584"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maceira</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Ripoll</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cosin-Sales</surname><given-names>J.</given-names></name><name name-style="western"><surname>Igual</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gavilan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Salazar</surname><given-names>J.</given-names></name><name name-style="western"><surname>Belloch</surname><given-names>V.</given-names></name><name name-style="western"><surname>Pennell</surname><given-names>D.J.</given-names></name></person-group><article-title>Long term effects of cocaine on the heart assessed by cardiovascular magnetic resonance at 3T</article-title><source>J. Cardiovasc. Magn. Reson.</source><year>2014</year><volume>16</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.1186/1532-429X-16-26</pub-id><pub-id pub-id-type="pmid">24758161</pub-id><pub-id pub-id-type="pmcid">PMC4026110</pub-id></element-citation></ref><ref id="B46-ijms-20-00584"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hale</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Alker</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Rezkalla</surname><given-names>S.</given-names></name><name name-style="western"><surname>Figures</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kloner</surname><given-names>R.A.</given-names></name></person-group><article-title>Adverse effects of cocaine on cardiovascular dynamics, myocardial blood flow, and coronary artery diameter in an experimental model</article-title><source>Am. Heart J.</source><year>1989</year><volume>118</volume><fpage>927</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1016/0002-8703(89)90226-3</pub-id><pub-id pub-id-type="pmid">2816705</pub-id></element-citation></ref><ref id="B47-ijms-20-00584"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pitts</surname><given-names>W.R.</given-names></name><name name-style="western"><surname>Vongpatanasin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Cigarroa</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Hillis</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Lange</surname><given-names>R.A.</given-names></name></person-group><article-title>Effects of the intracoronary infusion of cocaine on left ventricular systolic and diastolic function in humans</article-title><source>Circulation</source><year>1998</year><volume>97</volume><fpage>1270</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.97.13.1270</pub-id><pub-id pub-id-type="pmid">9570197</pub-id></element-citation></ref><ref id="B48-ijms-20-00584"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hale</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Alker</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Rezkalla</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Eisenhauer</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Kloner</surname><given-names>R.A.</given-names></name></person-group><article-title>Nifedipine protects the heart from the acute deleterious effects of cocaine if administered before but not after cocaine</article-title><source>Circulation</source><year>1991</year><volume>83</volume><fpage>1437</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.83.4.1437</pub-id><pub-id pub-id-type="pmid">2013159</pub-id></element-citation></ref><ref id="B49-ijms-20-00584"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gardin</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>N.</given-names></name><name name-style="western"><surname>Alker</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hale</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Paynter</surname><given-names>J.</given-names></name><name name-style="western"><surname>Knoll</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jamison</surname><given-names>B.</given-names></name><name name-style="western"><surname>Patterson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kloner</surname><given-names>R.A.</given-names></name></person-group><article-title>Acute cocaine administration induces ventricular regional wall motion and ultrastructural abnormalities in an anesthetized rabbit model</article-title><source>Am. Heart J.</source><year>1994</year><volume>128</volume><fpage>1117</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1016/0002-8703(94)90742-0</pub-id><pub-id pub-id-type="pmid">7985592</pub-id></element-citation></ref><ref id="B50-ijms-20-00584"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Restrepo</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Rojas</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>S.</given-names></name><name name-style="western"><surname>Riascos</surname><given-names>R.</given-names></name><name name-style="western"><surname>Marmol-Velez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Carrillo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vargas</surname><given-names>D.</given-names></name></person-group><article-title>Cardiovascular complications of cocaine: Imaging findings</article-title><source>Emerg. Radiol.</source><year>2009</year><volume>16</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1007/s10140-008-0762-x</pub-id><pub-id pub-id-type="pmid">18773229</pub-id></element-citation></ref><ref id="B51-ijms-20-00584"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Said</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alkhateeb</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Trien</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ajmal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Blandon</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>G.T.</given-names></name></person-group><article-title>Dilated cardiomyopathy secondary to chronic cocaine abuse: A case report</article-title><source>BMC Res. Notes</source><year>2013</year><volume>6</volume><elocation-id>536</elocation-id><pub-id pub-id-type="doi">10.1186/1756-0500-6-536</pub-id><pub-id pub-id-type="pmid">24341463</pub-id><pub-id pub-id-type="pmcid">PMC3866926</pub-id></element-citation></ref><ref id="B52-ijms-20-00584"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phillips</surname><given-names>K.</given-names></name><name name-style="western"><surname>Luk</surname><given-names>A.</given-names></name><name name-style="western"><surname>Soor</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Leong</surname><given-names>S.</given-names></name><name name-style="western"><surname>Butany</surname><given-names>J.</given-names></name></person-group><article-title>Cocaine cardiotoxicity: A review of the pathophysiology, pathology, and treatment options</article-title><source>Am. J. Cardiovasc. Drugs</source><year>2009</year><volume>9</volume><fpage>177</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1007/BF03256574</pub-id><pub-id pub-id-type="pmid">19463023</pub-id></element-citation></ref><ref id="B53-ijms-20-00584"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Felker</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Hare</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Hruban</surname><given-names>R.H.</given-names></name><name name-style="western"><surname>Baughman</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Kasper</surname><given-names>E.K.</given-names></name></person-group><article-title>The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients</article-title><source>Medicine (Baltimore)</source><year>1999</year><volume>78</volume><fpage>270</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1097/00005792-199907000-00005</pub-id><pub-id pub-id-type="pmid">10424207</pub-id></element-citation></ref><ref id="B54-ijms-20-00584"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brickner</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Willard</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Eichhorn</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Black</surname><given-names>J.</given-names></name><name name-style="western"><surname>Grayburn</surname><given-names>P.A.</given-names></name></person-group><article-title>Left ventricular hypertrophy associated with chronic cocaine abuse</article-title><source>Circulation</source><year>1991</year><volume>84</volume><fpage>1130</fpage><lpage>1135</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.84.3.1130</pub-id><pub-id pub-id-type="pmid">1832090</pub-id></element-citation></ref><ref id="B55-ijms-20-00584"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nahas</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Trouve</surname><given-names>R.</given-names></name><name name-style="western"><surname>Manger</surname><given-names>W.M.</given-names></name></person-group><article-title>Cocaine, catecholamines and cardiac toxicity</article-title><source>Acta. Anaesthesiol. Scand. Suppl.</source><year>1990</year><volume>94</volume><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.1990.tb03226.x</pub-id><pub-id pub-id-type="pmid">2291394</pub-id></element-citation></ref><ref id="B56-ijms-20-00584"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kloner</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Hale</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alker</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rezkalla</surname><given-names>S.</given-names></name></person-group><article-title>The effects of acute and chronic cocaine use on the heart</article-title><source>Circulation</source><year>1992</year><volume>85</volume><fpage>407</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.85.2.407</pub-id><pub-id pub-id-type="pmid">1346509</pub-id></element-citation></ref><ref id="B57-ijms-20-00584"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolodgie</surname><given-names>F.D.</given-names></name><name name-style="western"><surname>Virmani</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cornhill</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Herderick</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Smialek</surname><given-names>J.</given-names></name></person-group><article-title>Increase in atherosclerosis and adventitial mast cells in cocaine abusers: An alternative mechanism of cocaine-associated coronary vasospasm and thrombosis</article-title><source>J. Am. Coll. Cardiol.</source><year>1991</year><volume>17</volume><fpage>1553</fpage><lpage>1560</lpage><pub-id pub-id-type="doi">10.1016/0735-1097(91)90646-Q</pub-id><pub-id pub-id-type="pmid">2033185</pub-id></element-citation></ref><ref id="B58-ijms-20-00584"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patrizi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pasceri</surname><given-names>V.</given-names></name><name name-style="western"><surname>Sciahbasi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Summaria</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rosano</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Lioy</surname><given-names>E.</given-names></name></person-group><article-title>Evidence of cocaine-related coronary atherosclerosis in young patients with myocardial infarction</article-title><source>J. Am. Coll. Cardiol.</source><year>2006</year><volume>47</volume><fpage>2120</fpage><lpage>2122</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2005.12.060</pub-id><pub-id pub-id-type="pmid">16697335</pub-id></element-citation></ref><ref id="B59-ijms-20-00584"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minor</surname><given-names>R.L.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Scott</surname><given-names>B.D.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>Winniford</surname><given-names>M.D.</given-names></name></person-group><article-title>Cocaine-induced myocardial infarction in patients with normal coronary arteries</article-title><source>Ann. Intern. Med.</source><year>1991</year><volume>115</volume><fpage>797</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-115-10-797</pub-id><pub-id pub-id-type="pmid">1929028</pub-id></element-citation></ref><ref id="B60-ijms-20-00584"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Havranek</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>Nademanee</surname><given-names>K.</given-names></name><name name-style="western"><surname>Grayburn</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Eichhorn</surname><given-names>E.J.</given-names></name></person-group><article-title>Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy</article-title><source>J. Am. Coll. Cardiol.</source><year>1996</year><volume>28</volume><fpage>1168</fpage><lpage>1174</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(96)00299-9</pub-id><pub-id pub-id-type="pmid">8890811</pub-id></element-citation></ref><ref id="B61-ijms-20-00584"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Berger</surname><given-names>O.</given-names></name><name name-style="western"><surname>Stins</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Way</surname><given-names>D.</given-names></name><name name-style="western"><surname>Taub</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>House</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Weinand</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Cocaine enhances brain endothelial adhesion molecules and leukocyte migration</article-title><source>Clin. Immunol.</source><year>1999</year><volume>91</volume><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1006/clim.1998.4683</pub-id><pub-id pub-id-type="pmid">10219256</pub-id></element-citation></ref><ref id="B62-ijms-20-00584"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simpson</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>W.D.</given-names></name></person-group><article-title>Pathogenesis of cocaine-induced ischemic heart disease. Autopsy findings in a 21-year-old man</article-title><source>Arch. Pathol. Lab. Med.</source><year>1986</year><volume>110</volume><fpage>479</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">3754719</pub-id></element-citation></ref><ref id="B63-ijms-20-00584"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>P.K.</given-names></name></person-group><article-title>Mechanisms of plaque vulnerability and rupture</article-title><source>J. Am. Coll. Cardiol.</source><year>2003</year><volume>41</volume><issue>Suppl. S4</issue><fpage>15S</fpage><lpage>22S</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(02)02834-6</pub-id><pub-id pub-id-type="pmid">12644336</pub-id></element-citation></ref><ref id="B64-ijms-20-00584"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindstedt</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Mayranpaa</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Kovanen</surname><given-names>P.T.</given-names></name></person-group><article-title>Mast cells in vulnerable atherosclerotic plaques&#8212;A view to a kill</article-title><source>J. Cell. Mol. Med.</source><year>2007</year><volume>11</volume><fpage>739</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1111/j.1582-4934.2007.00052.x</pub-id><pub-id pub-id-type="pmid">17760836</pub-id><pub-id pub-id-type="pmcid">PMC3823253</pub-id></element-citation></ref><ref id="B65-ijms-20-00584"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kokkonen</surname><given-names>J.O.</given-names></name><name name-style="western"><surname>Kovanen</surname><given-names>P.T.</given-names></name></person-group><article-title>Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1987</year><volume>84</volume><fpage>2287</fpage><lpage>2291</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.8.2287</pub-id><pub-id pub-id-type="pmid">3470793</pub-id><pub-id pub-id-type="pmcid">PMC304635</pub-id></element-citation></ref><ref id="B66-ijms-20-00584"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kokkonen</surname><given-names>J.O.</given-names></name><name name-style="western"><surname>Kovanen</surname><given-names>P.T.</given-names></name></person-group><article-title>Proteolytic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages in vitro</article-title><source>J. Biol. Chem.</source><year>1989</year><volume>264</volume><fpage>10749</fpage><lpage>10755</lpage><pub-id pub-id-type="pmid">2659592</pub-id></element-citation></ref><ref id="B67-ijms-20-00584"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Letourneau</surname><given-names>R.</given-names></name><name name-style="western"><surname>Boucher</surname><given-names>W.</given-names></name><name name-style="western"><surname>Theoharides</surname><given-names>T.C.</given-names></name></person-group><article-title>Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice</article-title><source>Cardiovasc. Res.</source><year>2002</year><volume>55</volume><fpage>150</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/S0008-6363(02)00336-X</pub-id><pub-id pub-id-type="pmid">12062718</pub-id></element-citation></ref><ref id="B68-ijms-20-00584"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bohm</surname><given-names>M.</given-names></name><name name-style="western"><surname>La Rosee</surname><given-names>K.</given-names></name><name name-style="western"><surname>Schwinger</surname><given-names>R.H.</given-names></name><name name-style="western"><surname>Erdmann</surname><given-names>E.</given-names></name></person-group><article-title>Evidence for reduction of norepinephrine uptake sites in the failing human heart</article-title><source>J. Am. Coll. Cardiol.</source><year>1995</year><volume>25</volume><fpage>146</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/0735-1097(94)00353-R</pub-id><pub-id pub-id-type="pmid">7798493</pub-id></element-citation></ref><ref id="B69-ijms-20-00584"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Billman</surname><given-names>G.E.</given-names></name></person-group><article-title>Cocaine: A review of its toxic actions on cardiac function</article-title><source>Crit. Rev. Toxicol.</source><year>1995</year><volume>25</volume><fpage>113</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.3109/10408449509021610</pub-id><pub-id pub-id-type="pmid">7612173</pub-id></element-citation></ref><ref id="B70-ijms-20-00584"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hobbs</surname><given-names>W.E.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Penkala</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Bolgiano</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>J.A.</given-names></name></person-group><article-title>Cocaine and specific cocaine metabolites induce von Willebrand factor release from endothelial cells in a tissue-specific manner</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2013</year><volume>33</volume><fpage>1230</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.113.301436</pub-id><pub-id pub-id-type="pmid">23539221</pub-id><pub-id pub-id-type="pmcid">PMC3739701</pub-id></element-citation></ref><ref id="B71-ijms-20-00584"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heesch</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Wilhelm</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Ristich</surname><given-names>J.</given-names></name><name name-style="western"><surname>Adnane</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bontempo</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>W.R.</given-names></name></person-group><article-title>Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans</article-title><source>Heart</source><year>2000</year><volume>83</volume><fpage>688</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1136/heart.83.6.688</pub-id><pub-id pub-id-type="pmid">10814631</pub-id><pub-id pub-id-type="pmcid">PMC1760877</pub-id></element-citation></ref><ref id="B72-ijms-20-00584"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moons</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Levi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Peters</surname><given-names>R.J.</given-names></name></person-group><article-title>Tissue factor and coronary artery disease</article-title><source>Cardiovasc. Res.</source><year>2002</year><volume>53</volume><fpage>313</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1016/S0008-6363(01)00452-7</pub-id><pub-id pub-id-type="pmid">11827681</pub-id></element-citation></ref><ref id="B73-ijms-20-00584"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Herrera</surname><given-names>G.A.</given-names></name></person-group><article-title>Thrombotic microangiopathy in cocaine abuse-associated malignant hypertension: Report of 2 cases with review of the literature</article-title><source>Arch. Pathol. Lab. Med.</source><year>2007</year><volume>131</volume><fpage>1817</fpage><lpage>1820</lpage><pub-id pub-id-type="pmid">18081441</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5858/2007-131-1817-TMICAM</pub-id></element-citation></ref><ref id="B74-ijms-20-00584"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fogo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Superdock</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Atkinson</surname><given-names>J.B.</given-names></name></person-group><article-title>Severe arteriosclerosis in the kidney of a cocaine addict</article-title><source>Am. J. Kidney Dis.</source><year>1992</year><volume>20</volume><fpage>513</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/S0272-6386(12)70267-6</pub-id><pub-id pub-id-type="pmid">1442765</pub-id></element-citation></ref><ref id="B75-ijms-20-00584"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Altura</surname><given-names>B.</given-names></name><name name-style="western"><surname>Altura</surname><given-names>B.</given-names></name></person-group><article-title>Cocaine induces apoptosis in primary cultured rat aortic vascular smooth muscle cells: Possible relationship to aortic dissection, atherosclerosis, and hypertension</article-title><source>Int. J. Toxicol.</source><year>2004</year><volume>23</volume><fpage>233</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1080/10915810490471361</pub-id><pub-id pub-id-type="pmid">15371167</pub-id></element-citation></ref><ref id="B76-ijms-20-00584"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dabbouseh</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Ardelt</surname><given-names>A.</given-names></name></person-group><article-title>Cocaine mediated apoptosis of vascular cells as a mechanism for carotid artery dissection leading to ischemic stroke</article-title><source>Med. Hypotheses</source><year>2011</year><volume>77</volume><fpage>201</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.mehy.2011.04.011</pub-id><pub-id pub-id-type="pmid">21546166</pub-id></element-citation></ref><ref id="B77-ijms-20-00584"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramondo</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Mistrorigo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Angelini</surname><given-names>A.</given-names></name></person-group><article-title>Intimal hyperplasia and cystic medial necrosis as substrate of acute coronary syndrome in a cocaine abuser: An in vivo/ex vivo pathological correlation</article-title><source>Heart</source><year>2009</year><volume>95</volume><fpage>82</fpage><pub-id pub-id-type="doi">10.1136/hrt.2007.140509</pub-id><pub-id pub-id-type="pmid">19047443</pub-id></element-citation></ref><ref id="B78-ijms-20-00584"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steinhauer</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Caulfield</surname><given-names>J.B.</given-names></name></person-group><article-title>Spontaneous coronary artery dissection associated with cocaine use: A case report and brief review</article-title><source>Cardiovasc. Pathol.</source><year>2001</year><volume>10</volume><fpage>141</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/S1054-8807(01)00074-6</pub-id><pub-id pub-id-type="pmid">11485859</pub-id></element-citation></ref><ref id="B79-ijms-20-00584"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamineni</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sadhu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alpert</surname><given-names>J.S.</given-names></name></person-group><article-title>Spontaneous coronary artery dissection: Report of two cases and a 50-year review of the literature</article-title><source>Cardiol. Rev.</source><year>2002</year><volume>10</volume><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1097/00045415-200209000-00004</pub-id><pub-id pub-id-type="pmid">12215191</pub-id></element-citation></ref><ref id="B80-ijms-20-00584"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meghani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Siddique</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>T.</given-names></name><name name-style="western"><surname>Samarneh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Elsayegh</surname><given-names>S.</given-names></name></person-group><article-title>Internal carotid artery redundancy and dissection in a young cocaine abuser</article-title><source>Vascular</source><year>2013</year><volume>21</volume><fpage>243</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1177/1708538113478765</pub-id><pub-id pub-id-type="pmid">23539068</pub-id></element-citation></ref><ref id="B81-ijms-20-00584"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kozor</surname><given-names>R.</given-names></name><name name-style="western"><surname>Grieve</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Buchholz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kaye</surname><given-names>S.</given-names></name><name name-style="western"><surname>Darke</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bhindi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Figtree</surname><given-names>G.A.</given-names></name></person-group><article-title>Regular cocaine use is associated with increased systolic blood pressure, aortic stiffness and left ventricular mass in young otherwise healthy individuals</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e89710</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0089710</pub-id><pub-id pub-id-type="pmid">24717541</pub-id><pub-id pub-id-type="pmcid">PMC3981670</pub-id></element-citation></ref><ref id="B82-ijms-20-00584"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kariyanna</surname><given-names>P.T.</given-names></name><name name-style="western"><surname>Jayarangaiah</surname><given-names>A.</given-names></name><name name-style="western"><surname>Al-Sadawi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>R.</given-names></name><name name-style="western"><surname>Green</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dubson</surname><given-names>I.</given-names></name><name name-style="western"><surname>McFarlane</surname><given-names>S.I.</given-names></name></person-group><article-title>A rare case of second degree Mobitz type II AV block associated with cocaine use</article-title><source>Am. J. Med. Case Rep.</source><year>2018</year><volume>6</volume><fpage>146</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.12691/ajmcr-6-7-7</pub-id></element-citation></ref><ref id="B83-ijms-20-00584"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satran</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bart</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Henry</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Murad</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Talukdar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Satran</surname><given-names>D.</given-names></name><name name-style="western"><surname>Henry</surname><given-names>T.D.</given-names></name></person-group><article-title>Increased prevalence of coronary artery aneurysms among cocaine users</article-title><source>Circulation</source><year>2005</year><volume>111</volume><fpage>2424</fpage><lpage>2429</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000165121.50527.DE</pub-id><pub-id pub-id-type="pmid">15883217</pub-id></element-citation></ref><ref id="B84-ijms-20-00584"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>N.</given-names></name><name name-style="western"><surname>Washam</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Mountantonakis</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Roe</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>de Lemos</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Arora</surname><given-names>R.</given-names></name></person-group><article-title>Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry)</article-title><source>Am. J. Cardiol.</source><year>2014</year><volume>113</volume><fpage>749</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2013.11.023</pub-id><pub-id pub-id-type="pmid">24388623</pub-id></element-citation></ref><ref id="B85-ijms-20-00584"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salihu</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Salemi</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Steele</surname><given-names>B.F.</given-names></name><name name-style="western"><surname>Pepper</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Mogos</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Aliyu</surname><given-names>M.H.</given-names></name></person-group><article-title>Opioid drug use and acute cardiac events among pregnant women in the United States</article-title><source>Am. J. Med.</source><year>2018</year><volume>131</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.amjmed.2017.07.023</pub-id><pub-id pub-id-type="pmid">28807713</pub-id></element-citation></ref><ref id="B86-ijms-20-00584"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aslibekyan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Levitan</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Mittleman</surname><given-names>M.A.</given-names></name></person-group><article-title>Prevalent cocaine use and myocardial infarction</article-title><source>Am. J. Cardiol.</source><year>2008</year><volume>102</volume><fpage>966</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2008.06.016</pub-id><pub-id pub-id-type="pmid">18929694</pub-id><pub-id pub-id-type="pmcid">PMC2575126</pub-id></element-citation></ref><ref id="B87-ijms-20-00584"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gunja</surname><given-names>A.</given-names></name><name name-style="western"><surname>Stanislawski</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Baron</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Maddox</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Vidovich</surname><given-names>M.I.</given-names></name></person-group><article-title>The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program</article-title><source>Clin. Cardiol.</source><year>2018</year><volume>41</volume><fpage>809</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1002/clc.22961</pub-id><pub-id pub-id-type="pmid">29652077</pub-id><pub-id pub-id-type="pmcid">PMC6489926</pub-id></element-citation></ref><ref id="B88-ijms-20-00584"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arora</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dodani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kaeley</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Kraemer</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Aldridge</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pomm</surname><given-names>R.</given-names></name></person-group><article-title>Cocaine use and subclinical coronary artery disease in Caucasians</article-title><source>J. Clin. Exp. Cardiol.</source><year>2015</year><volume>6</volume><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="B89-ijms-20-00584"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bamberg</surname><given-names>F.</given-names></name><name name-style="western"><surname>Schlett</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Truong</surname><given-names>Q.A.</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Koenig</surname><given-names>W.</given-names></name><name name-style="western"><surname>Nagurney</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Seneviratne</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lehman</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Cury</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Abbara</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Presence and extent of coronary artery disease by cardiac computed tomography and risk for acute coronary syndrome in cocaine users among patients with chest pain</article-title><source>Am. J. Cardiol.</source><year>2009</year><volume>103</volume><fpage>620</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2008.11.011</pub-id><pub-id pub-id-type="pmid">19231323</pub-id><pub-id pub-id-type="pmcid">PMC3716451</pub-id></element-citation></ref><ref id="B90-ijms-20-00584"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Shofer</surname><given-names>F.S.</given-names></name><name name-style="western"><surname>McCusker</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Litt</surname><given-names>H.I.</given-names></name><name name-style="western"><surname>Hollander</surname><given-names>J.E.</given-names></name></person-group><article-title>Relationship between cocaine use and coronary artery disease in patients with symptoms consistent with an acute coronary syndrome</article-title><source>Acad. Emerg. Med.</source><year>2011</year><volume>18</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1553-2712.2010.00955.x</pub-id><pub-id pub-id-type="pmid">21182565</pub-id></element-citation></ref><ref id="B91-ijms-20-00584"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>R.</given-names></name><name name-style="western"><surname>Celentano</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>Gerstenblith</surname><given-names>G.</given-names></name><name name-style="western"><surname>Treisman</surname><given-names>G.</given-names></name><name name-style="western"><surname>Keruly</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Kickler</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>S.</given-names></name><etal/></person-group><article-title>HIV infection itself may not be associated with subclinical coronary artery disease among African Americans without cardiovascular symptoms</article-title><source>J. Am. Heart Assoc.</source><year>2016</year><volume>5</volume><fpage>e002529</fpage><pub-id pub-id-type="doi">10.1161/JAHA.115.002529</pub-id><pub-id pub-id-type="pmid">27013538</pub-id><pub-id pub-id-type="pmcid">PMC4943239</pub-id></element-citation></ref><ref id="B92-ijms-20-00584"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lucas</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Atta</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Fine</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>McFall</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Estrella</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Zook</surname><given-names>K.</given-names></name><name name-style="western"><surname>Stein</surname><given-names>J.H.</given-names></name></person-group><article-title>HIV, cocaine use, and hepatitis C virus: A triad of nontraditional risk factors for subclinical cardiovascular disease</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2016</year><volume>36</volume><fpage>2100</fpage><lpage>2107</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.116.307985</pub-id><pub-id pub-id-type="pmid">27609369</pub-id><pub-id pub-id-type="pmcid">PMC5033718</pub-id></element-citation></ref><ref id="B93-ijms-20-00584"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeFilippis</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Divakaran</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Biery</surname><given-names>D.</given-names></name><name name-style="western"><surname>Qamar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fatima</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ramsis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pipilas</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Cocaine and marijuana use among young adults with myocardial infarction</article-title><source>J. Am. Coll. Cardiol.</source><year>2018</year><volume>71</volume><fpage>2540</fpage><lpage>2551</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2018.02.047</pub-id><pub-id pub-id-type="pmid">29535062</pub-id><pub-id pub-id-type="pmcid">PMC6495189</pub-id></element-citation></ref><ref id="B94-ijms-20-00584"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morentin</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ballesteros</surname><given-names>J.</given-names></name><name name-style="western"><surname>Callado</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Meana</surname><given-names>J.J.</given-names></name></person-group><article-title>Recent cocaine use is a significant risk factor for sudden cardiovascular death in 15&#8211;49-year-old subjects: A forensic case-control study</article-title><source>Addiction</source><year>2014</year><volume>109</volume><fpage>2071</fpage><lpage>2078</lpage><pub-id pub-id-type="doi">10.1111/add.12691</pub-id><pub-id pub-id-type="pmid">25041688</pub-id></element-citation></ref><ref id="B95-ijms-20-00584"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qureshi</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>Chaudhry</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Suri</surname><given-names>M.F.</given-names></name></person-group><article-title>Cocaine use and the likelihood of cardiovascular and all-cause mortality: Data from the third national health and nutrition examination survey mortality follow-up study</article-title><source>J. Vasc. Interv. Neurol.</source><year>2014</year><volume>7</volume><fpage>76</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1212/WNL.78.1_MeetingAbstracts.P07.031</pub-id><pub-id pub-id-type="pmid">24920992</pub-id><pub-id pub-id-type="pmcid">PMC4051909</pub-id></element-citation></ref><ref id="B96-ijms-20-00584"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hser</surname><given-names>Y.I.</given-names></name><name name-style="western"><surname>Kagihara</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Evans</surname><given-names>E.</given-names></name><name name-style="western"><surname>Messina</surname><given-names>N.</given-names></name></person-group><article-title>Mortality among substance-using mothers in California: A 10-year prospective study</article-title><source>Addiction</source><year>2012</year><volume>107</volume><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.2011.03613.x</pub-id><pub-id pub-id-type="pmid">21831178</pub-id><pub-id pub-id-type="pmcid">PMC3226896</pub-id></element-citation></ref><ref id="B97-ijms-20-00584"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atoui</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fida</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nayudu</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Glandt</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chilimuri</surname><given-names>S.</given-names></name></person-group><article-title>Outcomes of patients with cocaine induced chest pain in an inner city hospital</article-title><source>Cardiol. Res.</source><year>2011</year><volume>2</volume><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.4021/cr103w</pub-id><pub-id pub-id-type="pmid">28352394</pub-id><pub-id pub-id-type="pmcid">PMC5358254</pub-id></element-citation></ref><ref id="B98-ijms-20-00584"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hollander</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Hoffman</surname><given-names>R.S.</given-names></name></person-group><article-title>Cocaine-induced myocardial infarction: An analysis and review of the literature</article-title><source>J. Emerg. Med.</source><year>1992</year><volume>10</volume><fpage>169</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/0736-4679(92)90212-C</pub-id><pub-id pub-id-type="pmid">1607624</pub-id></element-citation></ref><ref id="B99-ijms-20-00584"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pletcher</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Kiefe</surname><given-names>C.I.</given-names></name><name name-style="western"><surname>Sidney</surname><given-names>S.</given-names></name><name name-style="western"><surname>Carr</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Hulley</surname><given-names>S.B.</given-names></name></person-group><article-title>Cocaine and coronary calcification in young adults: The Coronary Artery Risk Development in Young Adults (CARDIA) study</article-title><source>Am. Heart J.</source><year>2005</year><volume>150</volume><fpage>921</fpage><lpage>926</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2005.04.016</pub-id><pub-id pub-id-type="pmid">16290964</pub-id></element-citation></ref><ref id="B100-ijms-20-00584"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Vlahov</surname><given-names>D.</given-names></name><name name-style="western"><surname>Celentano</surname><given-names>D.</given-names></name><name name-style="western"><surname>Strathdee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>K.</given-names></name><name name-style="western"><surname>Fishman</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Lima</surname><given-names>J.A.</given-names></name></person-group><article-title>Effect of cocaine use on coronary calcium among black adults in Baltimore, Maryland</article-title><source>Am. J. Cardiol.</source><year>2002</year><volume>90</volume><fpage>326</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/S0002-9149(02)02475-X</pub-id><pub-id pub-id-type="pmid">12127624</pub-id></element-citation></ref><ref id="B101-ijms-20-00584"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lima</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Vlahov</surname><given-names>D.</given-names></name><name name-style="western"><surname>Celentano</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Bartlett</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Margolick</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fishman</surname><given-names>E.K.</given-names></name></person-group><article-title>Human immunodeficiency virus 1 infection, cocaine, and coronary calcification</article-title><source>Arch. Intern. Med.</source><year>2005</year><volume>165</volume><fpage>690</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1001/archinte.165.6.690</pub-id><pub-id pub-id-type="pmid">15795348</pub-id></element-citation></ref><ref id="B102-ijms-20-00584"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fishman</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cofrancesco</surname><given-names>J.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Pannu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Du</surname><given-names>J.</given-names></name><name name-style="western"><surname>Barlett</surname><given-names>J.</given-names></name></person-group><article-title>Long-term cocaine use and antiretroviral therapy are associated with silent coronary artery disease in African Americans with HIV infection who have no cardiovascular symptoms</article-title><source>Clin. Infect. Dis.</source><year>2008</year><volume>46</volume><fpage>600</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1086/526782</pub-id><pub-id pub-id-type="pmid">19641630</pub-id><pub-id pub-id-type="pmcid">PMC2716694</pub-id></element-citation></ref><ref id="B103-ijms-20-00584"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Volkow</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pappas</surname><given-names>N.R.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Netusil</surname><given-names>N.</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>J.S.</given-names></name></person-group><article-title>Brain dopamine and obesity</article-title><source>Lancet</source><year>2001</year><volume>357</volume><fpage>354</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(00)03643-6</pub-id><pub-id pub-id-type="pmid">11210998</pub-id></element-citation></ref><ref id="B104-ijms-20-00584"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volkow</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Baler</surname><given-names>R.D.</given-names></name></person-group><article-title>Reward, dopamine and the control of food intake: Implications for obesity</article-title><source>Trends Cogn. Sci.</source><year>2011</year><volume>15</volume><fpage>37</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.tics.2010.11.001</pub-id><pub-id pub-id-type="pmid">21109477</pub-id><pub-id pub-id-type="pmcid">PMC3124340</pub-id></element-citation></ref><ref id="B105-ijms-20-00584"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahapatra</surname><given-names>A.</given-names></name></person-group><article-title>Overeating, obesity, and dopamine receptors</article-title><source>ACS Chem. Neurosci.</source><year>2010</year><volume>1</volume><fpage>346</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1021/cn100044y</pub-id><pub-id pub-id-type="pmid">22778831</pub-id><pub-id pub-id-type="pmcid">PMC3368677</pub-id></element-citation></ref><ref id="B106-ijms-20-00584"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thanos</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>R.</given-names></name><name name-style="western"><surname>Michaelides</surname><given-names>M.</given-names></name><name name-style="western"><surname>Primeaux</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bray</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Volkow</surname><given-names>N.D.</given-names></name></person-group><article-title>Bromocriptine increased operant responding for high fat food but decreased chow intake in both obesity-prone and resistant rats</article-title><source>Behav. Brain Res.</source><year>2011</year><volume>217</volume><fpage>165</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2010.10.027</pub-id><pub-id pub-id-type="pmid">21034777</pub-id><pub-id pub-id-type="pmcid">PMC3018148</pub-id></element-citation></ref><ref id="B107-ijms-20-00584"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramamoorthy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bauman</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Han</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang-Feng</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Ganapathy</surname><given-names>V.</given-names></name><name name-style="western"><surname>Blakely</surname><given-names>R.D.</given-names></name></person-group><article-title>Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1993</year><volume>90</volume><fpage>2542</fpage><lpage>2546</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.6.2542</pub-id><pub-id pub-id-type="pmid">7681602</pub-id><pub-id pub-id-type="pmcid">PMC46124</pub-id></element-citation></ref><ref id="B108-ijms-20-00584"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yadav</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Oury</surname><given-names>F.</given-names></name><name name-style="western"><surname>Suda</surname><given-names>N.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.W.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X.B.</given-names></name><name name-style="western"><surname>Confavreux</surname><given-names>C.</given-names></name><name name-style="western"><surname>Klemenhagen</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>K.F.</given-names></name><name name-style="western"><surname>Gingrich</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X.E.</given-names></name><etal/></person-group><article-title>A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure</article-title><source>Cell</source><year>2009</year><volume>138</volume><fpage>976</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.06.051</pub-id><pub-id pub-id-type="pmid">19737523</pub-id><pub-id pub-id-type="pmcid">PMC2768582</pub-id></element-citation></ref><ref id="B109-ijms-20-00584"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vicentic</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>D.C.</given-names></name></person-group><article-title>The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2007</year><volume>320</volume><fpage>499</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1124/jpet.105.091512</pub-id><pub-id pub-id-type="pmid">16840648</pub-id></element-citation></ref><ref id="B110-ijms-20-00584"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogge</surname><given-names>G.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hubert</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kuha</surname><given-names>M.J.</given-names></name></person-group><article-title>CART peptides: Regulators of body weight, reward and other functions</article-title><source>Nat. Rev. Neurosci.</source><year>2008</year><volume>9</volume><fpage>747</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1038/nrn2493</pub-id><pub-id pub-id-type="pmid">18802445</pub-id><pub-id pub-id-type="pmcid">PMC4418456</pub-id></element-citation></ref><ref id="B111-ijms-20-00584"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wortley</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>G.Q.</given-names></name><name name-style="western"><surname>Davydova</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Fried</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Leibowitz</surname><given-names>S.F.</given-names></name></person-group><article-title>Cocaine- and amphetamine-regulated transcript in the arcuate nucleus stimulates lipid metabolism to control body fat accrual on a high-fat diet</article-title><source>Regul. Pept.</source><year>2004</year><volume>117</volume><fpage>89</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.regpep.2003.08.005</pub-id><pub-id pub-id-type="pmid">14700744</pub-id></element-citation></ref><ref id="B112-ijms-20-00584"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunter</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Philpot</surname><given-names>K.</given-names></name><name name-style="western"><surname>Vicentic</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dominguez</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hubert</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>Kuhar</surname><given-names>M.J.</given-names></name></person-group><article-title>CART in feeding and obesity</article-title><source>Trends Endocrinol. Metab.</source><year>2004</year><volume>15</volume><fpage>454</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1016/S1043-2760(04)00220-6</pub-id><pub-id pub-id-type="pmid">15519893</pub-id></element-citation></ref><ref id="B113-ijms-20-00584"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balopole</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Hansult</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Dorph</surname><given-names>D.</given-names></name></person-group><article-title>Effect of cocaine on food intake in rats</article-title><source>Psychopharmacology</source><year>1979</year><volume>64</volume><fpage>121</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1007/BF00427356</pub-id><pub-id pub-id-type="pmid">113823</pub-id></element-citation></ref><ref id="B114-ijms-20-00584"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolgin</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Hertz</surname><given-names>J.M.</given-names></name></person-group><article-title>Effects of acute and chronic cocaine on milk intake, body weight, and activity in bottle- and cannula-fed rats</article-title><source>Behav. Pharmacol.</source><year>1995</year><volume>6</volume><fpage>746</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1097/00008877-199511000-00010</pub-id><pub-id pub-id-type="pmid">11224377</pub-id></element-citation></ref><ref id="B115-ijms-20-00584"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Church</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Morbach</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Subramanian</surname><given-names>M.G.</given-names></name></person-group><article-title>Comparative effects of prenatal cocaine, alcohol, and undernutrition on maternal/fetal toxicity and fetal body composition in the Sprague-Dawley rat with observations on strain-dependent differences</article-title><source>Neurotoxicol. Teratol.</source><year>1995</year><volume>17</volume><fpage>559</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1016/0892-0362(95)00016-K</pub-id><pub-id pub-id-type="pmid">8552002</pub-id></element-citation></ref><ref id="B116-ijms-20-00584"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castro</surname><given-names>F.G.</given-names></name><name name-style="western"><surname>Newcomb</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Cadish</surname><given-names>K.</given-names></name></person-group><article-title>Lifestyle differences between young adult cocaine users and their nonuser peers</article-title><source>J. Drug Educ.</source><year>1987</year><volume>17</volume><fpage>89</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.2190/878H-U394-UKN3-DVD5</pub-id><pub-id pub-id-type="pmid">3612421</pub-id></element-citation></ref><ref id="B117-ijms-20-00584"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ersche</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Stochl</surname><given-names>J.</given-names></name><name name-style="western"><surname>Woodward</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Fletcher</surname><given-names>P.C.</given-names></name></person-group><article-title>The skinny on cocaine: Insights into eating behavior and body weight in cocaine-dependent men</article-title><source>Appetite</source><year>2013</year><volume>71</volume><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.appet.2013.07.011</pub-id><pub-id pub-id-type="pmid">23920064</pub-id><pub-id pub-id-type="pmcid">PMC3863945</pub-id></element-citation></ref><ref id="B118-ijms-20-00584"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quach</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Wanke</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Schmid</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Gorbach</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Mwamburi</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Spiegelman</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>A.M.</given-names></name></person-group><article-title>Drug use and other risk factors related to lower body mass index among HIV-infected individuals</article-title><source>Drug Alcohol Depend.</source><year>2008</year><volume>95</volume><fpage>30</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2007.12.004</pub-id><pub-id pub-id-type="pmid">18243579</pub-id><pub-id pub-id-type="pmcid">PMC3837518</pub-id></element-citation></ref><ref id="B119-ijms-20-00584"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Escobar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Scherer</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Soares</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Guimaraes</surname><given-names>L.S.P.</given-names></name><name name-style="western"><surname>Hagen</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>von Diemen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pechansky</surname><given-names>F.</given-names></name></person-group><article-title>Active Brazilian crack cocaine users: Nutritional, anthropometric, and drug use profiles</article-title><source>Braz. J. Psychiatry</source><year>2018</year><volume>40</volume><fpage>354</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1590/1516-4446-2017-2409</pub-id><pub-id pub-id-type="pmid">29451589</pub-id><pub-id pub-id-type="pmcid">PMC6899369</pub-id></element-citation></ref><ref id="B120-ijms-20-00584"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muniz</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Evans</surname><given-names>T.</given-names></name></person-group><article-title>Acute gastrointestinal manifestations associated with use of crack</article-title><source>Am. J. Emerg. Med.</source><year>2001</year><volume>19</volume><fpage>61</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1053/ajem.2001.20010</pub-id><pub-id pub-id-type="pmid">11146022</pub-id></element-citation></ref><ref id="B121-ijms-20-00584"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Billing</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ersche</surname><given-names>K.D.</given-names></name></person-group><article-title>Cocaine&#8217;s appetite for fat and the consequences on body weight</article-title><source>Am. J. Drug Alcohol Abuse</source><year>2015</year><volume>41</volume><fpage>115</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.3109/00952990.2014.966196</pub-id><pub-id pub-id-type="pmid">25321424</pub-id></element-citation></ref><ref id="B122-ijms-20-00584"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ludwig</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Kroenke</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Hilner</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Van Horn</surname><given-names>L.</given-names></name><name name-style="western"><surname>Slattery</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>D.R.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults</article-title><source>JAMA</source><year>1999</year><volume>282</volume><fpage>1539</fpage><lpage>1546</lpage><pub-id pub-id-type="doi">10.1001/jama.282.16.1539</pub-id><pub-id pub-id-type="pmid">10546693</pub-id></element-citation></ref><ref id="B123-ijms-20-00584"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rangel</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shu</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Lazar</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Vittinghoff</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hsue</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>Marcus</surname><given-names>G.M.</given-names></name></person-group><article-title>Beta-blockers for chest pain associated with recent cocaine use</article-title><source>Arch. Intern. Med.</source><year>2010</year><volume>170</volume><fpage>874</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1001/archinternmed.2010.115</pub-id><pub-id pub-id-type="pmid">20498415</pub-id></element-citation></ref><ref id="B124-ijms-20-00584"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopez</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Akinlonu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mene-Afejuku</surname><given-names>T.O.</given-names></name><name name-style="western"><surname>Dumancas</surname><given-names>C.</given-names></name><name name-style="western"><surname>Saeed</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cativo</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Visco</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mushiyev</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pekler</surname><given-names>G.</given-names></name></person-group><article-title>Clinical outcomes of B-blocker therapy in cocaine-associated heart failure</article-title><source>Int. J. Cardiol.</source><year>2018</year><pub-id pub-id-type="doi">10.1016/S0735-1097(18)31427-X</pub-id><pub-id pub-id-type="pmid">30146248</pub-id></element-citation></ref><ref id="B125-ijms-20-00584"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dattilo</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Hailpern</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Fearon</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sohal</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nordin</surname><given-names>C.</given-names></name></person-group><article-title>Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use</article-title><source>Ann. Emerg. Med.</source><year>2008</year><volume>51</volume><fpage>117</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.annemergmed.2007.04.015</pub-id><pub-id pub-id-type="pmid">17583376</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-20-00584-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Effects of cocaine on cardiovascular health. Use of cocaine (bottom) results in both acute (italic) and chronic (normal) changes in the heart (left) and blood vessels (right). (Note: Cocaine often induces cardiac condition(s) (e.g., acute myocardial infarction (MI) and coronary artery disease) by affecting the heart and vessels simultaneously).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ijms-20-00584-g001.jpg"/></fig><table-wrap id="ijms-20-00584-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-20-00584-t001_Table 1</object-id><label>Table 1</label><caption><p>Acute and chronic effects of cocaine on the cardiovascular system.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study (year)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Data Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Population (Sample Size)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Male %, Age (mean &#177; SD)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Outcome(s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Findings</th></tr></thead><tbody><tr><td colspan="8" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Acute effects of cocaine</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kozor et al. (2014) [<xref rid="B81-ijms-20-00584" ref-type="bibr">81</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Australia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study participants</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adults with no coronary disease, no previous MI, no contraindication to CMR imaging, and no cocaine use in the 48 h prior to image acquisition (<italic toggle="yes">n</italic> = 20 for social cocaine users; <italic toggle="yes">n</italic> = 20 for cocaine non-users)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85%, 37 &#177; 7 yrs in the social cocaine users&#8217; group; 95%, 33 &#177; 7 yrs in the cocaine nonusers group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systolic blood pressure, aortic stiffness, and LV mass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cocaine use associated with high systolic blood pressure (134 &#177; 11 vs. 126 &#177; 11 mmHg), increased aortic stiffness, and greater LV mass (124 &#177; 25 vs. 105 &#177; 16 g) compared with no cocaine use</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sharma et al. (2016) [<xref rid="B43-ijms-20-00584" ref-type="bibr">43</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ECG recordings in the Atherosclerosis Risk in Communities (ARIC) study from Aug. 2006 to Dec. 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cocaine-dependent subjects (<italic toggle="yes">n</italic> = 97); non-cocaine-using control subjects (<italic toggle="yes">n</italic> = 8513)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86%, 50 &#177; 4 yrs in the cocaine-dependent subjects&#8217; group; 46%, 52 &#177; 5 yrs in the controls group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resting ECG parameters</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Significant effects of cocaine use on early repolarization (OR = 4.92, 95% CI: 2.73&#8211;8.87), bradycardia (OR = 3.02, 95% CI: 1.95-4.66), severe bradycardia (OR = 5.11, 95% CI: 2.95-8.84), and heart rate (B weight = &#8722;5.84, 95% CI: &#8722;7.85 to &#8722;3.82)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kariyanna et al. (2018) [<xref rid="B82-ijms-20-00584" ref-type="bibr">82</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patient</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A 55-year-old woman presenting with a chest pain after cocaine use (<italic toggle="yes">n</italic> = 1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0%, 55 yrs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Second degree Mobitz type II atrioventricular block</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cocaine-induced Mobitz type II second degree atrioventricular block</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Satran et al. (2005) [<xref rid="B83-ijms-20-00584" ref-type="bibr">83</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Angiographic database at Hennepin County Medical Center in Minnesota</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients with a history of cocaine use (<italic toggle="yes">n</italic> = 112); Patients with no history of cocaine use (<italic toggle="yes">n</italic> = 79)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79%, 44 &#177; 8 yrs in the cocaine users&#8217; group; 61%, 46 &#177; 5 yrs in the cocaine non-users group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CAA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Significantly higher CAA in cocaine users compared with cocaine nonusers (30.4% vs. 7.6%)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gupta et al. (2014) <sup>1</sup> [<xref rid="B84-ijms-20-00584" ref-type="bibr">84</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines (ACTION Registry-GWTG)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients admitted within 24 h of acute MI from July 2008 to March 2010 (<italic toggle="yes">n</italic> = 924 in the cocaine group; <italic toggle="yes">n</italic> = 102,028 in the non-cocaine group)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80%, 50 (range: 44&#8211;56) yrs in the cocaine group; 65%, 64 (range: 54&#8211;76) yrs in the non-cocaine group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute STEMI, cardiogenic shock, multivessel CAD, and in-hospital mortality</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Higher percentages of STEMI (46.3% vs. 39.7%) and cardiogenic shock (13% vs. 4.4%) in the cocaine group, but a lower percentage of multivessel coronary artery disease (53.3% vs. 64.5%). Similar in-hospital mortality between the cocaine group and the non-cocaine group (OR = 1.00, 95% CI: 0.69&#8211;1.44)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salihu et al. (2018) [<xref rid="B85-ijms-20-00584" ref-type="bibr">85</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">National Inpatient Sample (NIS) from Jan. 2002 to Dec. 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pregnant women aged 13-49 yrs who had pregnancy-related inpatient hospitalizations (<italic toggle="yes">n</italic> = 153,608 cocaine users; <italic toggle="yes">n</italic> = 56,882,258 non-drug users)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0%, Age group: 13&#8211;24 (21.4%); 25&#8211;34 (55.4%); 35&#8211;49 (20.5%) in the cocaine users&#8217; group; 0%, Age group: 13-24 (34.0%); 25&#8211;34 (51.3%); 35&#8211;49 (14.7%) in the non-drug users&#8217; group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute MI or cardiac arrest</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cocaine use associated with acute MI or cardiac arrest (adjusted OR = 1.83, 95% CI: 1.28&#8211;2.62)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aslibekyan et al. (2008) [<xref rid="B86-ijms-20-00584" ref-type="bibr">86</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">National Health and Nutrition Examination Survey (NHANES) in 1988&#8211;1994 and 2005&#8211;2006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Civilian non-institutionalized US adults (a) aged 18-59 (<italic toggle="yes">n</italic> = 11,993); (b) aged 18-45 (<italic toggle="yes">n</italic> = 9337)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(a) 46%, 36 yrs (N/R); (b) 39%, 31 yrs (N/R)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevalence of MI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(a) No significant association between cocaine use and MI in the 18&#8211;59 age group; (b) Significant association between cocaine use of &gt; 10 lifetime instances and MI in the 18&#8211;45 age group (aged-adjusted OR = 4.60, 95% CI: 1.12&#8211;18.88), but this association was attenuated in the multivariate-adjusted model (OR = 3.84, 95% CI: 0.98&#8211;15.07)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gunja et al. (2018) <sup>2</sup> [<xref rid="B87-ijms-20-00584" ref-type="bibr">87</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Veterans Affairs database</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Veterans with CAD undergoing cardiac catheterization from Oct. 2007 to Sep. 2014 (<italic toggle="yes">n</italic> = 3082 in the cocaine group; <italic toggle="yes">n</italic> = 118,953 in the non-cocaine group)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">98.6%, median age: 58 (IQR: 54&#8211;62) yrs in the cocaine group; 98.6%, median age: 65 (IQR: 61&#8211;72) yrs in the non-cocaine group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MI and 1-year all-cause mortality</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">With adjustment of basic cardiac risk factors, cocaine use was significantly associated with MI (HR = 1.40, 95% CI: 1.07&#8211;1.83) and mortality (HR = 1.23, 95% CI: 1.08&#8211;1.39). After adjustment for risky behaviors, cocaine use was associated with mortality (HR = 1.22, 95% CI: 1.04&#8211;1.42), but not with MI (HR = 1.17, 95% CI: 0.87&#8211;1.56). After adjustment for causal pathway conditions, mortality was no longer significant (HR = 1.15, 95% CI: 0.99&#8211;1.33)</td></tr><tr><td colspan="8" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Chronic effects of cocaine</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maceira et al. (2014) [<xref rid="B45-ijms-20-00584" ref-type="bibr">45</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spain </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study participants and a gender and age matched healthy group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cocaine abusers attending a rehabilitation clinic for the first time (<italic toggle="yes">n</italic> = 94)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86%, 37 &#177; 7 yrs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cocaine cardiotoxicity using a CMR protocol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased LV end-systolic volume, LV mass index, and RV end-systolic volume, and decreased LV ejection fraction and RV ejection fraction in cocaine abusers compared with those in the gender and age matched healthy group</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arora et al. (2015) [<xref rid="B88-ijms-20-00584" ref-type="bibr">88</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Drug treatment center in Florida</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caucasian adults with cocaine use disorder (<italic toggle="yes">n</italic> = 33)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33%, 37 &#177; 9 yrs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Presence of subclinical CAD using CIMT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No association between chronic cocaine use and subclinical CAD measured by CIMT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bamberg et al. (2009) [<xref rid="B89-ijms-20-00584" ref-type="bibr">89</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nested matched cohort</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Massachusetts General Hospital</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients who presented to the emergency department with acute chest pain in May to July, 2005 (<italic toggle="yes">n</italic> = 44 in the cocaine group; <italic toggle="yes">n</italic> = 132 in the non-cocaine group)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86%, 46 &#177; 7 yrs in the cocaine group; 86%, 46 &#177; 7 yrs in the non-cocaine group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ACS and CAD using coronary CT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Significant association of cocaine use with increased risk of ACS group (OR = 5.79, 95% CI: 1.24&#8211;27.02), but no association with coronary stenosis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chang et al. (2011) [<xref rid="B90-ijms-20-00584" ref-type="bibr">90</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">University of Pennsylvania Hospital</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients who received coronary CTA for evaluation of CAD in the emergency department from May 2005 to Dec. 2008 (<italic toggle="yes">n</italic> = 157 in the cocaine group; <italic toggle="yes">n</italic> = 755 in the non-cocaine group)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58%, 46 &#177; 6 yrs in the cocaine group; 40%, 48 &#177; 9 yrs in the non-cocaine group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CAD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No association between recent cocaine use and the presence of coronary lesions &#8805; 25% (adjusted RR = 0.92, 95% CI: 0.58&#8211;1.45) and coronary lesions &#8805; 50% (adjusted RR = 0.96, 95% CI: 0.46&#8211;2.01)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lai et al. (2016) [<xref rid="B91-ijms-20-00584" ref-type="bibr">91</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study participants</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">African American adults with/without HIV infection in Baltimore (<italic toggle="yes">n</italic> = 737 in the cocaine group; <italic toggle="yes">n</italic> = 692 in the non-cocaine group)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.3%, 45 (IQR: 40&#8211;50) yrs in the entire population</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Subclinical CAD defined by the presence of CAC detected by noncontrast CT and/or coronary plaque detected by contrast-enhanced coronary CT angiography</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic cocaine use associated with high risk for subclinical CAD (propensity score-adjusted prevalence ratio = 1.27, 95% CI: 1.08&#8211;1.49), CAC (propensity score-adjusted prevalence ratio=1.26, 95% CI: 1.05&#8211;1.52), any coronary stenosis (propensity score-adjusted prevalence ratio = 1.30, 95% CI: 1.08&#8211;1.57), and calcified plaques (propensity score-adjusted prevalence ratio = 1.37, 95% CI: 1.10&#8211;1.71)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lucas et al. (2016) [<xref rid="B92-ijms-20-00584" ref-type="bibr">92</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional and longitudinal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study participants</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adults with/without human immunodeficiency virus infection in Baltimore (<italic toggle="yes">n</italic> = 57 never cocaine users; <italic toggle="yes">n</italic> = 82 past cocaine users; <italic toggle="yes">n</italic> = 153 current cocaine users)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67%, 46 (IQR: 41&#8211;53) yrs in the never users; 66%, 51 (IQR: 46&#8211;54) yrs in the past users; 75%, 49 (IQR:45&#8211;52) yrs in the current users</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Subclinical CVD: carotid artery plaque</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cocaine use associated with approximately three-fold higher odds of carotid plaques at baseline (OR = 3.3, 95% CI: 1.5&#8211;7.3 for past cocaine users vs. cocaine nonusers; OR = 2.7, 95% CI: 1.3&#8211;5.5 for the current cocaine users vs. cocaine nonusers) </td></tr><tr><td colspan="8" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Cocaine effects on mortality</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DeFilippis et al. (2018) [<xref rid="B93-ijms-20-00584" ref-type="bibr">93</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective cohort </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two academic medical centers (Brigham and Women&#8217;s Hospital and Massachusetts General Hospital)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients presenting with an MI at &#8804;50 years between 2000 and 2016 (<italic toggle="yes">n</italic> = 99 in the cocaine group; 1873 in the non-cocaine group)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85%, 44 (range: 40&#8211;46) yrs in the cocaine group; 80%, 45 (range: 42&#8211;48) yrs in the non-cocaine group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cardiovascular mortality and all-cause mortality</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Significant association of cocaine use with cardiovascular mortality (HR = 2.32, 95% CI: 1.11&#8211;4.85) and all-cause mortality (HR = 1.91, 95% CI: 1.11&#8211;3.29)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Morentin et al. (2014) [<xref rid="B94-ijms-20-00584" ref-type="bibr">94</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-control retrospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forensic autopsy reports in Biscay, Spain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All SCVD in individuals aged 15&#8211;49 (<italic toggle="yes">n</italic> = 311); SnoCVD (<italic toggle="yes">n</italic> = 126) from Jan. 2003 to Dec. 2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82%, 41 &#177; 7 yrs in SCVD; 71%, 39 &#177; 7 yrs in SnoCVD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cocaine detected in blood</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cocaine being the risk for SCVD (OR = 4.10; 95% CI: 1.12&#8211;15.0)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Qureshi et al. (2014) [<xref rid="B95-ijms-20-00584" ref-type="bibr">95</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NHANES in 1988-1994</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Civilian non-institutionalized US adults aged 18&#8211;45 (<italic toggle="yes">n</italic> = 7751 cocaine nonusers; <italic toggle="yes">n</italic> = 730 infrequent cocaine users (1&#8211;10 times); <italic toggle="yes">n</italic> = 354 frequent cocaine users (&gt;10 times); <italic toggle="yes">n</italic> = 178 regular cocaine users (&gt;100 times))</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43%, 31 &#177; 8 yrs in the cocaine non-users&#8217; group; 59%, 31&#177;10 yrs in the infrequent cocaine users group; 65%, 33 &#177; 9 yrs in the frequent cocaine users group; 70%, 33 &#177; 7 yrs in the regular cocaine users group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cardiovascular mortality and all-cause mortality</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regular lifetime cocaine use was associated with high all-cause mortality (RR = 1.9, 95% CI: 1.2&#8211;3.0), but not cardiovascular mortality (RR = 0.6, 95% CI: 0.1&#8211;4.7) compared with cocaine nonusers</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hser et al. (2012) [<xref rid="B96-ijms-20-00584" ref-type="bibr">96</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective cohort</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">California Treatment Outcome Project (CalTOP) between 2000 and 2002, the National Death Index by 2008, the National Death Register by 2010, and the California Department of Mental Health</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Women admitted to 40 drug abuse treatment programs through CalTOP (<italic toggle="yes">n</italic> = 4,253 for those alive in 2010; <italic toggle="yes">n</italic> = 194 for those deceased by 2010)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0%, 33 &#177; 8 yrs for living; 0% 37 &#177; 7 yrs for the deceased </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 to 10-year mortality</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cocaine was associated with higher mortality relative to methamphetamine (HR = 3.56, 95% CI: 1.95&#8211;6.48)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Atoui et al. (2011) [<xref rid="B97-ijms-20-00584" ref-type="bibr">97</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective chart review</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Electronic medical records in Bronx Lebanon Hospital Center</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients admitted with chest pain to the hospital who had no cardiovascular risk factors from July 2009 to June 2010 (<italic toggle="yes">n</italic> = 54 in the cocaine group; <italic toggle="yes">n</italic> = 372 in the non-cocaine group)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59%, 44 &#177; 10 yrs in the cocaine group; 49%, 43 &#177; 12 yrs in the non-cocaine group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Length of stay and mortality</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant difference in length of stay (3.0 vs. 2.4) and in-hospital mortality (0% vs. 1%) between the cocaine group and the non-cocaine group</td></tr></tbody></table><table-wrap-foot><fn><p>ACS: Acute coronary syndrome; CAA: Coronary artery aneurysm; CAC: Coronary artery calcium; CAD: Coronary artery disease; CI: Confidence interval; CIMT: Carotid intima media thickness; CMR: Cardiovascular magnetic resonance; CT: Computed tomography; CTA: Computerized tomographic angiography; CVD: Cardiovascular disease; ECG: Electrocardiogram; HR: Hazard ratio; IQR: Interquartile range; LV: Left ventricular; MI: Myocardial infarction; N/R: not reported; OR: Odds ratio; RR: Relative risk; RV: Right ventricular; SCVD: Sudden cardiovascular death; SnoCVD: Sudden death not due to cardiovascular diseases; STEMI: ST elevation myocardial infarction. <sup>1</sup> Including acute effects (i.e., acute STEMI and cardiogenic shock) and chronic effect (i.e., multivessel CAD) of cocaine and mortality as the study outcomes. <sup>2</sup> Including acute effect of cocaine (i.e., MI) and 1-year all-cause mortality as the study outcomes.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>